<!DOCTYPE HTML>
<html lang="en-gb" class="no-js">
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1"/>
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=2.5,user-scalable=yes">
    <meta name="citation_publisher" content="Springer Vienna"/>
    <meta name="citation_title" content="Glutamate and α-ketoglutarate: key players in glioma metabolism"/>
    <meta name="citation_doi" content="10.1007/s00726-016-2342-9"/>
    <meta name="citation_language" content="en"/>
    <meta name="citation_abstract_html_url" content="https://link.springer.com/article/10.1007/s00726-016-2342-9"/>
    <meta name="citation_fulltext_html_url" content="https://link.springer.com/article/10.1007/s00726-016-2342-9"/>
    <meta name="citation_pdf_url" content="https://link.springer.com/content/pdf/10.1007%2Fs00726-016-2342-9.pdf"/>
    <meta name="citation_springer_api_url" content="http://api.springer.com/metadata/pam?q&#x3D;doi:10.1007/s00726-016-2342-9&amp;api_key&#x3D;"/>
    <meta name="citation_firstpage" content="21"/>
    <meta name="citation_lastpage" content="32"/>
    <meta name="citation_author" content="Andreas Maus"/>
    <meta name="citation_author_institution" content="VU University Medical Center"/>
    <meta name="citation_author_institution" content="University of Gottingen"/>
    <meta name="citation_author" content="Godefridus J. Peters"/>
    <meta name="citation_author_institution" content="VU University Medical Center"/>
    <meta name="citation_author_email" content="gj.peters@vumc.nl"/>
    <meta name="dc.identifier" content="10.1007/s00726-016-2342-9"/>
    <meta name="format-detection" content="telephone&#x3D;no"/>
    <meta name="citation_fulltext_world_readable" content=""/>
    <meta name="meta:description" content="Glioblastoma multiforme (GBM), or grade IV astrocytoma, is the most common type of primary brain tumor. It has a devastating prognosis with a 2-year-overall survival rate of only 26 % after standard t"/>
    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:title" content="Glutamate and α-ketoglutarate: key players in glioma metabolism"/>
    <meta name="twitter:description" content="Glioblastoma multiforme (GBM), or grade IV astrocytoma, is the most common type of primary brain tumor. It has a devastating prognosis with a 2-year-overall survival rate of only 26 % after standard t"/>
    <meta name="twitter:image" content="https://static-content.springer.com/cover/journal/726/49/1.jpg"/>
    <meta name="twitter:image:alt" content="Content cover image"/>
    <meta name="twitter:site" content="SpringerLink"/>
    <meta name="citation_journal_title" content="Amino Acids"/>
    <meta name="citation_journal_abbrev" content="Amino Acids"/>
    <meta name="citation_volume" content="49"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_issn" content="0939-4451"/>
    <meta name="citation_issn" content="1438-2199"/>
    <meta name="citation_online_date" content="2016/10/17"/>
    <meta name="citation_cover_date" content="2017/01/01"/>
    <meta name="citation_article_type" content="Review Article"/>
    <meta property="og:title" content="Glutamate and α-ketoglutarate: key players in glioma metabolism"/>
    <meta property="og:description" content="Glioblastoma multiforme (GBM), or grade IV astrocytoma, is the most common type of primary brain tumor. It has a devastating prognosis with a 2-year-overall survival rate of only 26 % after standard t"/>
    <meta property="og:type" content="Article"/>
    <meta property="og:url" content="https://link.springer.com/article/10.1007/s00726-016-2342-9"/>
    <meta property="og:image" content="https://link.springer.com/springerlink-static/25538376/images/png/SL-Square.png"/>
    <meta property="og:site_name" content="SpringerLink"/>

        <title>Glutamate and α-ketoglutarate: key players in glioma metabolism | SpringerLink</title>
        <link rel="canonical" href="https://link.springer.com/article/10.1007/s00726-016-2342-9"/>
        <link rel="shortcut icon" href="/springerlink-static/25538376/images/favicon/favicon.ico" />
<link rel="icon" sizes="16x16 32x32 48x48" href="/springerlink-static/25538376/images/favicon/favicon.ico">
<link rel="icon" sizes="16x16" type="image/png" href="/springerlink-static/25538376/images/favicon/favicon-16x16.png">
<link rel="icon" sizes="32x32" type="image/png" href="/springerlink-static/25538376/images/favicon/favicon-32x32.png">
<link rel="icon" sizes="48x48" type="image/png" href="/springerlink-static/25538376/images/favicon/favicon-48x48.png">
<link rel="apple-touch-icon" href="/springerlink-static/25538376/images/favicon/app-icon-iphone@3x.png">
<link rel="apple-touch-icon" sizes="72x72" href="/springerlink-static/25538376/images/favicon/ic_launcher_hdpi.png" />
<link rel="apple-touch-icon" sizes="76x76" href="/springerlink-static/25538376/images/favicon/app-icon-ipad.png" />
<link rel="apple-touch-icon" sizes="114x114" href="/springerlink-static/25538376/images/favicon/app-icon-114x114.png" />
<link rel="apple-touch-icon" sizes="120x120" href="/springerlink-static/25538376/images/favicon/app-icon-iphone@2x.png" />
<link rel="apple-touch-icon" sizes="144x144" href="/springerlink-static/25538376/images/favicon/ic_launcher_xxhdpi.png" />
<link rel="apple-touch-icon" sizes="152x152" href="/springerlink-static/25538376/images/favicon/app-icon-ipad@2x.png" />
<link rel="apple-touch-icon" sizes="180x180" href="/springerlink-static/25538376/images/favicon/app-icon-iphone@3x.png" />
<meta name="msapplication-TileColor" content="#ffffff">
<meta name="msapplication-TileImage" content="/springerlink-static/25538376/images/favicon/ic_launcher_xxhdpi.png">
        <link rel="dns-prefetch" href="//fonts.gstatic.com" />
<link rel="dns-prefetch" href="//fonts.googleapis.com" />
<link rel="dns-prefetch" href="//google-analytics.com" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//www.googletagservices.com" />
<link rel="dns-prefetch" href="//www.googletagmanager.com" />
<link rel="dns-prefetch" href="//static-content.springer.com" />
        <link rel="stylesheet" href="/springerlink-static/25538376/css/basic.css" media="screen">
<link rel="stylesheet" href="/springerlink-static/25538376/css/styles.css" class="js-ctm" media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)">
<link rel="stylesheet" href="/springerlink-static/25538376/css/print.css" media="print">


            <script id="webtrekk-properties">
    var webtrekkProperties = {
          trackDomain : "springergmbh01.webtrekk.net",
          trackId : "935649882378213",
      };
    </script>
    <script type="text/javascript" async src="/springerlink-static/25538376/js/webtrekk_v4.min.js"></script>

            <script>
        var dataLayer = [{
                'GA Key':'UA-26408784-1',
                'Event Category':'Article',
                'Open Access':'Y',
                'Labs':'Y',
                'DOI':'10.1007\/s00726-016-2342-9',
                'VG Wort Identifier':'vgzm.415900-10.1007-s00726-016-2342-9',
                'HasAccess':'Y',
                'Full HTML':'Y',
                'Has Body':'Y',
                'Static Hash':'25538376',
                'Has Preview':'N',
                'user':{'license': {'businessPartnerID': [], 'businessPartnerIDString': ''}},
                'content':{'type': 'article', 'category': {'pmc': {'primarySubject': 'Life Sciences', 'primarySubjectCode': 'L', 'secondarySubjects': {'4': 'Life Sciences, general', '5': 'Proteomics', '6': 'Neurobiology', '1': 'Biochemistry, general', '2': 'Analytical Chemistry', '3': 'Biochemical Engineering'}, 'secondarySubjectCodes': {'4': 'L00004', '5': 'L1403X', '6': 'L25066', '1': 'L14005', '2': 'C11006', '3': 'C12029'}}}},
                'Access Type':'subscription',
                'Page':'article',
                'Bpids':'',
                'Bpnames':'',
                'SubjectCodes':'SCL, SCL14005, SCC11006, SCC12029, SCL00004, SCL1403X, SCL25066',
                'Keywords':'Glioma, Glutamate, Alpha-ketoglutarate, Isocitrate dehydrogenase, Branched chain amino acids',
                'Webtrekk parent prefix':'journal',
                'Webtrekk leaf prefix':'article',
                'Webtrekk toc prefix':'journal',
                'Country':'IN',
                'Journal Id':'726',
                'Journal Title':'Amino Acids',
        }];
    </script>

    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
            new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
            j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
            'https://www.googletagmanager.com/gtm.js?cache-busting=' + new Date().getTime() + '&id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-WCF9Z9');</script>

    </head>
    <body>
        <noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-WCF9Z9"
                      height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>

    <nav class="skip-to">
    <a class="skip-to__link skip-to__link--article" href="#main-content" title="Skip directly to the main content">Skip to main content</a>
        <a class="skip-to__link skip-to__link--contents" href="#article-contents" title="Skip directly to section list">Skip to sections</a>
</nav>
        <div class="page-wrapper">
            <noscript>
    <div class="nojs-banner u-interface">
        <p>This service is more advanced with JavaScript available, learn more at <a
                href="http://activatejavascript.org" target="_blank" rel="noopener noreferrer">http://activatejavascript.org</a>
        </p>
    </div>
</noscript>
                    <div id="leaderboard" class="leaderboard u-hide" data-component="SpringerLink.GoogleAds" data-namespace="leaderboard"></div>

                <header id="header" class="header u-interface" role="banner">
        <div class="header__content">
            <div class="header__menu-container">
                    <a id="logo" class="site-logo" href="/" title="Go to homepage">
            <span class="u-screenreader-only">SpringerLink</span>
            <svg class="site-logo__springer" width="148" height="30" role="img" aria-label="SpringerLink Logo">
                <image width="148" height="30" alt="SpringerLink Logo" src="/springerlink-static/25538376/images/png/springerlink.png" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/springerlink-static/25538376/images/svg/springerlink.svg"></image>
            </svg>
    </a>


                    <nav id="search-container" class="u-inline-block">
                        <div class="search">
                            <div class="search__content">
                                <form class="u-form-single-input" action="/search" method="get" role="search">
    <input aria-label="Search" name="query" type="text" autocomplete="off" value="" placeholder="Search">
    <input class="u-hide-text" type="submit" value="Submit" title="Submit">
    <svg class="u-vertical-align-absolute" width="13" height="13" viewBox="222 151 13 13" version="1.1" xmlns="http://www.w3.org/2000/svg">
        <path d="M227 159C228.7 159 230 157.7 230 156 230 154.3 228.7 153 227 153 225.3 153 224 154.3 224 156 224 157.7 225.3 159 227 159L227 159 227 159 227 159ZM230 160.1L231.1 159 233.9 161.7C234.2 162.1 234.2 162.6 233.9 162.9 233.6 163.2 233.1 163.2 232.7 162.9L230 160.1 230 160.1 230 160.1 230 160.1ZM227 161L227 161C224.2 161 222 158.8 222 156 222 153.2 224.2 151 227 151 229.8 151 232 153.2 232 156 232 158.8 229.8 161 227 161L227 161 227 161 227 161 227 161Z" stroke="none" fill-rule="evenodd"/>
    </svg>
</form>
                            </div>
                        </div>
                    </nav>

                    <nav class="nav-container u-interface">
    <div class="global-nav__wrapper">
        <div class="search-button">
            <a class="search-button__label" href="#search-container">
                <span class="search-button__title">Search</span><svg width="12" height="12" viewBox="222 151 12 12" version="1.1" xmlns="http://www.w3.org/2000/svg">
                    <path d="M227 159C228.7 159 230 157.7 230 156 230 154.3 228.7 153 227 153 225.3 153 224 154.3 224 156 224 157.7 225.3 159 227 159L227 159 227 159 227 159ZM230 160.1L231.1 159 233.9 161.7C234.2 162.1 234.2 162.6 233.9 162.9 233.6 163.2 233.1 163.2 232.7 162.9L230 160.1 230 160.1 230 160.1 230 160.1ZM227 161L227 161C224.2 161 222 158.8 222 156 222 153.2 224.2 151 227 151 229.8 151 232 153.2 232 156 232 158.8 229.8 161 227 161L227 161 227 161 227 161 227 161Z" stroke="none" fill-rule="evenodd"></path>
                </svg>
            </a>
        </div>

        <ul class="global-nav" data-component="SpringerLink.Menu" data-title="Navigation menu" data-text="Menu">
            <li>
                <a href="/">
                    <span class="u-overflow-ellipsis">Home</span>
                </a>
            </li>
            <li>
                <a href="/contactus">
                    <span class="u-overflow-ellipsis">Contact Us</span>
                </a>
            </li>

                <li class="global-nav__logged-out">
                    <a class="test-login-link" href="//link.springer.com/signup-login?previousUrl=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%252Fs00726-016-2342-9">
                        <span class="u-overflow-ellipsis">Log in</span>
                    </a>
                </li>

        </ul>
    </div> 
</nav> 
            </div>

        </div>
    </header>

            
            

            <main id="main-content">
                <article class="main-wrapper">
                    <div class="main-container uptodate-recommendations-off">
                        <aside class="main-sidebar-left">
                            <div class="main-sidebar-left__content">
                                <div class="test-cover cover-image" itemscope>
        <a class="test-cover-link" href="/journal/726" title="Amino Acids">
            <img class="test-cover-image" src="https://static-content.springer.com/cover/journal/726/49/1.jpg" alt="Amino Acids" itemprop="image"/>
        </a>

</div>
                            </div>
                        </aside>

                        <div class="main-body" data-role="NavigationContainer">
                            <div class="main-body__content">
                                        <div class="cta-button-container u-hide-two-col">
                    <a href="/content/pdf/10.1007%2Fs00726-016-2342-9.pdf" target="_blank" class="c-button c-button--blue c-button__icon-right gtm-pdf-link" title="Download this article in PDF format" rel="noopener noreferrer">
            <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" version="1.1"><g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g fill="#fff"><g transform="translate(12.000000, 5.000000)"><path d="M7 7.3L7 1C7 0.4 6.6 0 6 0 5.4 0 5 0.4 5 1L5 7.3 3.5 5.7C3.1 5.3 2.5 5.3 2.1 5.7L2.1 5.7C1.7 6.1 1.7 6.7 2.1 7.1L5.3 10.3C5.7 10.7 6.3 10.7 6.7 10.3L9.9 7.1C10.3 6.7 10.3 6.1 9.9 5.7L9.9 5.7C9.5 5.3 8.9 5.3 8.5 5.7L7 7.3 7 7.3ZM0 13C0 12.4 0.5 12 1 12L11 12C11.6 12 12 12.4 12 13 12 13.6 11.5 14 11 14L1 14C0.4 14 0 13.6 0 13L0 13Z"/></g></g></g></svg>
            <span class="hide-text-small">Download</span>
            <span>PDF</span>
        </a>

        </div>



                                <div xmlns="http://www.w3.org/1999/xhtml" class="FulltextWrapper"><div class="ArticleHeader main-context"><div id="enumeration" class="enumeration"><p><a href="/journal/726" title="Amino Acids"><span class="JournalTitle">Amino Acids</span></a></p><p class="icon--meta-keyline-before"><span class="ArticleCitation_Year"><time datetime="2017-01">January 2017</time>, </span><span class="ArticleCitation_Volume">Volume 49, </span><a class="ArticleCitation_Issue" href="/journal/726/49/1/page/1">Issue 1</a>,
                       <span class="ArticleCitation_Pages"> pp 21–32</span></p></div><div class="MainTitleSection"><h1 class="ArticleTitle" lang="en">Glutamate and α-ketoglutarate: key players in glioma metabolism</h1></div><div class="authors u-clearfix" data-component="SpringerLink.Authors"><ul class="u-interface u-inline-list authors__title" data-role="AuthorsNavigation"><li><span>Authors</span></li><li><a href="#authorsandaffiliations" class="gtm-tab-authorsandaffiliations">Authors and affiliations</a></li></ul><div class="authors__list" data-role="AuthorsList"><ul class="test-contributor-names"><li itemscope="" itemtype="http://schema.org/Person" class="u-mb-2 u-pt-4 u-pb-4"><span itemprop="name" class="authors__name">Andreas Maus</span></li><li itemscope="" itemtype="http://schema.org/Person" class="u-mb-2 u-pt-4 u-pb-4"><span itemprop="name" class="authors__name">Godefridus J. Peters</span><span class="author-information"><span class="authors__contact"><a href="mailto:gj.peters@vumc.nl" title="gj.peters@vumc.nl" itemprop="email" class="gtm-email-author">Email author</a></span></span></li></ul></div></div><div class="main-context__container" data-component="SpringerLink.ArticleMetrics"><div class="main-context__column"><span><div id="open-choice-icon" class="open-access u-text-separator-after-micro"><abbr title="This content is freely available to anyone, anywhere, at any time">Open Access</abbr></div><span class="test-render-category">Review Article</span></span><div class="article-dates" data-component="SpringerLink.ArticleDates"><dl><dt>First Online: </dt><dd class="article-dates__first-online"><time datetime="2016-10-17">17 October 2016</time></dd></dl><dl class="article-dates__history"><dt>Received: </dt><dd><time datetime="2016-09-27">27 September 2016</time></dd><dt>Accepted: </dt><dd><time datetime="2016-09-28">28 September 2016</time></dd></dl></div></div>    <div class="main-context__column">
        <ul id="book-metrics" class="article-metrics">
                <li class="article-metrics__item">
                        <a class="article-metrics__link gtm-citations-count" href="http://citations.springer.com/item?doi&#x3D;10.1007/s00726-016-2342-9" target="_blank" rel="noopener noreferrer"
                           title="Visit Springer Citations for full citation details" id="citations-link">
                           <span id="citations-count-number" class="test-metric-count c-button-circle gtm-citations-count">3</span>
                           <span class="test-metric-name article-metrics__label gtm-citations-count">Citations</span>
                        </a>
                </li>
                <li class="article-metrics__item">
                        <a class="article-metrics__link gtm-socialmediamentions-count" href="http://www.altmetric.com/details.php?citation_id&#x3D;12962406&amp;domain&#x3D;link.springer.com" target="_blank" rel="noopener noreferrer"
                           title="Visit Altmetric for full social mention details" id="socialmediamentions-link">
                           <span id="socialmediamentions-count-number" class="test-metric-count c-button-circle gtm-socialmediamentions-count">1</span>
                           <span class="test-metric-name article-metrics__label gtm-socialmediamentions-count">Shares</span>
                        </a>
                </li>
                <li class="article-metrics__item">
                         <span class="article-metrics__views">1.8k</span>
                         <span class="article-metrics__label">Downloads</span>
                </li>
        </ul>
    </div>
</div></div><section class="Abstract" id="Abs1" tabindex="-1" lang="en"><h2 class="Heading">Abstract</h2><p id="Par1" class="Para">Glioblastoma multiforme (GBM), or grade IV astrocytoma, is the most common type of primary brain tumor. It has a devastating prognosis with a 2-year-overall survival rate of only 26 % after standard treatment, which includes surgery, radiation, and adjuvant chemotherapy with temozolomide. Also lower grade gliomas are difficult to treat, because they diffusely spread into the brain, where extensive removal of tissue is critical. Better understanding of the cancer’s biology is a key for the development of more effective therapy approaches. The discovery of isocitrate dehydrogenase (IDH) mutations in leukemia and glioma drew attention to specific metabolic aberrations in IDH-mutant gliomas. In the center of the metabolic alterations is α-ketoglutarate (αKG), an intermediate metabolite in the tricarboxylic acid (TCA) cycle, and the associated amino acid glutamate (Glu). This article highlights the role of these metabolites in glioma energy and lipid production and indicates possible weak spots of IDH-mutant and IDH-wt gliomas.</p></section><div class="KeywordGroup" lang="en"><h3 class="Heading">Keywords</h3><span class="Keyword">Glioma </span><span class="Keyword">Glutamate </span><span class="Keyword">Alpha-ketoglutarate </span><span class="Keyword">Isocitrate dehydrogenase </span><span class="Keyword">Branched chain amino acids </span></div><div class="AbbreviationGroup"><h3 class="Heading">Abbreviations</h3><div class="DefinitionList"><dl><dt class="Term">2HG</dt><dd class="Description"><p id="Par2" class="Para"><em class="EmphasisTypeItalic ">2</em>-Hydroxyglutarate (also known as 2-oxoglutarate)</p></dd><dt class="Term">ALL</dt><dd class="Description"><p id="Par3" class="Para">Acute lymphoblastic leukemia</p></dd><dt class="Term">Arg</dt><dd class="Description"><p id="Par4" class="Para">Arginine</p></dd><dt class="Term">AS</dt><dd class="Description"><p id="Par5" class="Para">Asparagine synthetase</p></dd><dt class="Term">Asn</dt><dd class="Description"><p id="Par6" class="Para">Asparagine</p></dd><dt class="Term">ASNase</dt><dd class="Description"><p id="Par7" class="Para">Asparaginase</p></dd><dt class="Term">BCAT1</dt><dd class="Description"><p id="Par8" class="Para">Branched-chain amino acid transaminase 1</p></dd><dt class="Term">Cys</dt><dd class="Description"><p id="Par9" class="Para">Cysteine</p></dd><dt class="Term">EGFR</dt><dd class="Description"><p id="Par10" class="Para">Epidermal growth factor receptor</p></dd><dt class="Term">G-CIMP</dt><dd class="Description"><p id="Par11" class="Para">Glioma-CpG island methylator phenotype</p></dd><dt class="Term">GBM</dt><dd class="Description"><p id="Par12" class="Para">Glioblastoma multiforme</p></dd><dt class="Term">GDH</dt><dd class="Description"><p id="Par13" class="Para">Glutamate dehydrogenase</p></dd><dt class="Term">GLA</dt><dd class="Description"><p id="Par14" class="Para">Glutaminase</p></dd><dt class="Term">Gln</dt><dd class="Description"><p id="Par15" class="Para">Glutamine</p></dd><dt class="Term">GLS</dt><dd class="Description"><p id="Par16" class="Para"><em class="EmphasisTypeItalic ">Gls</em> gene</p></dd><dt class="Term">Glu</dt><dd class="Description"><p id="Par17" class="Para">Glutamate</p></dd><dt class="Term">GSH</dt><dd class="Description"><p id="Par18" class="Para">(reduced) Glutathione</p></dd><dt class="Term">GSSG</dt><dd class="Description"><p id="Par19" class="Para">(oxidized) glutathione</p></dd><dt class="Term">IDH1</dt><dd class="Description"><p id="Par20" class="Para">Isocitrate dehydrogenase 1</p></dd><dt class="Term">IDH2</dt><dd class="Description"><p id="Par21" class="Para">Isocitrate dehydrogenase 2</p></dd><dt class="Term">JHDMs</dt><dd class="Description"><p id="Par22" class="Para">Jumonji-C-domain-containing histone demethylases</p></dd><dt class="Term">Met</dt><dd class="Description"><p id="Par23" class="Para">Methionine</p></dd><dt class="Term">MRS</dt><dd class="Description"><p id="Par24" class="Para">Magnetic resonance spectroscopy</p></dd><dt class="Term">mTOR</dt><dd class="Description"><p id="Par25" class="Para">Mechanistic target of rapamycin (or mammalian target of rapamycin)</p></dd><dt class="Term">mTORC1</dt><dd class="Description"><p id="Par26" class="Para">mTOR complex 1</p></dd><dt class="Term">mTORC2</dt><dd class="Description"><p id="Par27" class="Para">mTOR complex 2</p></dd><dt class="Term">PDH</dt><dd class="Description"><p id="Par28" class="Para">Pyruvate dehydrogenase</p></dd><dt class="Term">PPP</dt><dd class="Description"><p id="Par29" class="Para">Pentose phosphate pathway</p></dd><dt class="Term">ROS</dt><dd class="Description"><p id="Par30" class="Para">Reactive oxygen species</p></dd><dt class="Term">siRNA</dt><dd class="Description"><p id="Par31" class="Para">Small interfering RNA</p></dd><dt class="Term">TCA</dt><dd class="Description"><p id="Par32" class="Para">Tricarboxylic acid</p></dd><dt class="Term">TET</dt><dd class="Description"><p id="Par33" class="Para">Ten-eleven-translocation</p></dd><dt class="Term">wt</dt><dd class="Description"><p id="Par34" class="Para">Wild-type</p></dd><dt class="Term">αKG</dt><dd class="Description"><p id="Par35" class="Para">α-Ketoglutarate</p></dd></dl></div></div><div class="HeaderArticleNotes"><aside class="ArticleNote ArticleNoteMisc"><p class="SimplePara">An erratum to this article is available at <span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="http://dx.doi.org/10.1007/s00726-017-2414-5"><span class="RefSource">http://dx.doi.org/10.1007/s00726-017-2414-5</span></a></span>.</p></aside></div><div class="note test-pdf-link" id="cobranding-and-download-availability-text"><div>    <a class="gtm-pdf-link" href="/content/pdf/10.1007%2Fs00726-016-2342-9.pdf" target="_blank" rel="noreferrer noopener">Download</a>
 fulltext PDF</div></div><div class="article-actions--inline" id="article-actions--inline" data-component="article-actions--inline"></div><div id="body"><section id="Sec1" tabindex="-1" class="Section1 RenderAsSection1 SectionTypeIntroduction"><h2 class="Heading">Introduction</h2><div class="content"><p id="Par36" class="Para">Glutamic acid is an amino acid that plays an important role in energy metabolism and as excitatory neurotransmitter in the central nervous system. In the context of molecular biology the name of its carboxylate anion glutamate (Glu) is used synonymously, because in the body glutamic acid appears in its dissociated form. A link between Glu and energy metabolism was already described in the 1920s (Thunberg <span class="CitationRef"><a href="#CR62">1920</a></span>). In 1936—Malherbe showed that the reversible oxidation of Glu to α-ketoglutarate (αKG) could be found in brain tissue. He further hypothesized that in vivo the enzyme “glutamic acid deaminase”, today referred to as glutamate dehydrogenase (GDH), executes the synthesis of Glu more often than its degradation. One part of this article will elucidate under which circumstances Weil-Malherbe’s assumption is true.</p><div id="Par37" class="Para">αKG is an intermediate metabolite in the tricarboxylic acid (TCA) cycle (or citric acid cycle, or Krebs cycle). The TCA cycle is an evolutionary conserved pathway. In eukaryotic cells it takes place in the mitochondria and serves mainly the production of ATP by breakdown of macromolecules. The reactions yield the reducing agents NADH and NADPH, which are used in the electron transport (oxidative phosphorylation) pathway for ATP production. In addition the TCA cycle is crucial for providing substrates for lipid and fatty acid synthesis. The transamination of αKG produces Glu and, dependent on the amino acid, a keto-acid (Fig. <span class="InternalRef"><a href="#Fig1">1</a></span>). Amino acids like alanine or aspartate are converted to pyruvate or oxaloacetate, respectively. These products are important metabolites in pathways like the TCA cycle or glycolysis. It became extremely relevant to the field of cancer metabolism when isocitrate dehydrogenase 1/2 (IDH1/2) mutations in glioma and acute myeloid leukemia were discovered (Dang et al. <span class="CitationRef"><a href="#CR15">2010</a></span>; Reitman and Yan <span class="CitationRef"><a href="#CR53">2010</a></span>). Mutated IDH enzymes have a shifted functionality, with which αKG becomes the main substrate for 2-hydroxyglutarate (2HG) synthesis.<figure class="Figure" id="Fig1"><div class="MediaObject" id="MO1"><a href="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig1_HTML.gif" target="_blank" rel="noopener noreferrer"><span class="u-screenreader-only">Open image in new window</span><img src="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig1_HTML.gif" alt="" /></a></div><figcaption class="Caption" lang="en"><div class="CaptionContent"><span class="CaptionNumber">Fig. 1</span><p class="SimplePara">Glutamate dehydrogenase mediates the NADH-producing conversion of glutamate to α-ketoglutarate. From <span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://www.david-bender.co.uk"><span class="RefSource">https://www.david-bender.co.uk</span></a></span> (assessed 26-02-2016)</p></div></figcaption></figure></div><p id="Par38" class="Para">Aside from oxidative deamination, Glu is often synthesized from glutamine (Gln). Due to its role as neurotransmitter, Glu is constantly released from neurons. Its synthesis and degradation are part of the glutamate/glutamine cycle. After release Glu is taken up by astrocytes, where it is converted to Gln and released again (Bak et al. <span class="CitationRef"><a href="#CR4">2006</a></span>; Hertz <span class="CitationRef"><a href="#CR29">1979</a></span>; Hertz et al. <span class="CitationRef"><a href="#CR30">1999</a></span>). In the cytoplasm Gln can be converted to Glu by the enzyme glutaminase (GLA).</p><p id="Par39" class="Para">Gliomas account for 50 % of intracranial tumors and are the most common primary form of cancer in the brain. Glioblastoma multiforme (GBM; WHO grade IV astrocytoma) accounts for most of them. 12 % of GBMs carry a mutation in the <em class="EmphasisTypeItalic ">IDH1</em> gene, which encodes for the metabolic enzyme isocitrate dehydrogenase (Parsons et al. <span class="CitationRef"><a href="#CR51">2008</a></span>). The discovery of <em class="EmphasisTypeItalic ">IDH</em> mutations in gliomas led the focus on cancer metabolism. A better understanding of tumor genesis could increase the hope of finding effective treatments against it. Better treatment strategies are urgently needed, because the prognosis for gliomas, especially for GBM is abject. Standard treatment for GBM includes resection via surgery, followed by radiation and adjuvant chemotherapy with the alkylating agent temozolomide. Although administration of temozolomide improves overall survival significantly, median survival ranges in between 12 and 15 months and the 2-year survival rate averages 26 % (Stupp et al. <span class="CitationRef"><a href="#CR59">2005</a></span>).</p></div></section><section id="Sec2" tabindex="-1" class="Section1 RenderAsSection1"><h2 class="Heading">Glutamate and α-ketoglutarate in glioma metabolism</h2><div class="content"><section id="Sec3" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">The Warburg effect</h3><p id="Par40" class="Para">Otto Warburg described a metabolic switch in cancer cells concerning the use of glucose (Warburg et al. <span class="CitationRef"><a href="#CR69">1926</a></span>; Warburg <span class="CitationRef"><a href="#CR67">1925</a></span>, <span class="CitationRef"><a href="#CR68">1954</a></span>). In recent times the shift from pyruvate oxidation to lactic acid fermentation is known as the “Warburg-effect” and is considered a hallmark of cancer (Hanahan and Weinberg <span class="CitationRef"><a href="#CR27">2011</a></span>). The metabolic change to lactic acid fermentation is baffling at first, because it leads to a smaller net ATP production than pyruvate oxidation and therefore seems like a reduction of the cell’s energy production. Today it is widely believed that the Warburg effect enables the cell to have building blocks like amino acids and nucleosides readily available. They are crucial for the synthesis of macromolecules and organelles, which enable the cancer cell to meet the special needs regarding fast growth and proliferation. The switch is accompanied by an increased glucose influx, possibly to make up for the less efficient ATP production.</p></section><section id="Sec4" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Glutaminolysis</h3><p id="Par41" class="Para">Glu plays an important role as intermediate metabolite of glutaminolysis. Glutaminolysis describes the sequence of enzymatic reactions that turn glutamine (Gln) into substrates that enter the TCA cycle. The first step of this sequence is the hydrolysis of the amino group of Gln, which turns it into Glu. The reaction is mediated by glutaminase and can be displayed as: Glutamine + H<sub>2</sub>O → Glutamate + NH<sub>3</sub>. In cancer, glycolysis and glutaminolysis are the major mechanisms of ATP production, which means glucose and Gln are crucial nutrients. HIF1α activity can disrupt the function of the pyruvate dehydrogenase (PDH) complex (Kim et al. <span class="CitationRef"><a href="#CR37">2006</a></span>). This will inhibit the introduction of glucose-derived metabolites into the TCA cycle and therefore renders the cell dependent on glutaminolysis. Glutaminolysis alone can rescue the cell from cell death. It is a key enzymic pathway for cancer metabolism, because it provides nitrogen for nucleotide and amino acid synthesis, it offers an alternative carbon source to supply TCA cycle intermediates, and as a byproduct NADPH is formed for lipid and nucleotide synthesis (reviewed by DeBerardinis and Cheng <span class="CitationRef"><a href="#CR17">2010</a></span>).</p></section><section id="Sec5" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Reductive carboxylation</h3><div id="Par42" class="Para">Besides glutaminolysis, Gln can be a substrate for another distinct cytosolic pathway, which includes reversed flux through the TCA cycle. Where glutaminolysis mainly serves the production of energy in the form of ATP, reversed flux through the TCA cycle favors the synthesis of acetyl-CoA (Filipp et al. <span class="CitationRef"><a href="#CR21">2012</a></span>). In regular cell metabolism glucose-derived pyruvate will enter the TCA cycle and then serves as the main source of acetyl-CoA, a precursor of fatty acids and lipids (Fig. <span class="InternalRef"><a href="#Fig2">2</a></span>). Under conditional aerobic glycolysis or under hypoxic conditions cells convert glucose to lactate. This will reduce the flux of pyruvate into the TCA cycle. Acetyl-CoA is then produced by breakdown of the TCA cycle-metabolite citrate. Hence, a lack of acetyl-CoA could also stem from disabled citrate formation by defective mitochondria, such as disruptions in the TCA cycle or electron transport chain (Mullen et al. <span class="CitationRef"><a href="#CR47">2012</a></span>). In hypoxia HIF1α activity interferes with glucose carbon use in citrate synthesis by hampering PDH. A study performed with a GBM cell line in hypoxia (0.5 % O<sub>2</sub>) came to the conclusion that Gln is the major source for carbon under hypoxic conditions (Wise et al. <span class="CitationRef"><a href="#CR73">2011</a></span>). Additionally, it was shown that reductive carboxylation of αKG (from Gln) is IDH2-dependent (Fig. <span class="InternalRef"><a href="#Fig2">2</a></span>). IDH2 is known to catalyze the oxidative decarboxylation of isocitrate to αKG. Studies indicate that it is also crucial for the reverse reaction (Wise et al. <span class="CitationRef"><a href="#CR73">2011</a></span>; Mullen et al. <span class="CitationRef"><a href="#CR47">2012</a></span>). Although the studies showed that IDH2 is crucial for sustained reductive carboxylation under hypoxia, they failed to assess the importance of IDH1 in that matter.<figure class="Figure" id="Fig2"><div class="MediaObject" id="MO2"><a href="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig2_HTML.gif" target="_blank" rel="noopener noreferrer"><span class="u-screenreader-only">Open image in new window</span><img src="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig2_HTML.gif" alt="" /></a></div><figcaption class="Caption" lang="en"><div class="CaptionContent"><span class="CaptionNumber">Fig. 2</span><p class="SimplePara">Intact TCA cycle (<em class="EmphasisTypeItalic ">green</em>). When PDH is blocked, or the TCA cycle is disrupted for other reasons, IDH-dependent reductive carboxylation sustains the formation of intermediate metabolites and fatty acids (<em class="EmphasisTypeItalic ">red</em>). From Mullen et al. (<span class="CitationRef"><a href="#CR47">2012</a></span>) with permission</p></div></figcaption></figure></div><p id="Par43" class="Para">In contrast to these results it was shown that there is a TCA cycle-independent cytoplasmic pathway of reductive carboxylation of αKG, which is mediated by IDH1 (Metallo et al. <span class="CitationRef"><a href="#CR45">2012</a></span>). This pathway, too results in the formation of isocitrate, citrate, and finally in acetyl-CoA for lipid synthesis.</p><p id="Par44" class="Para">Another positive effect of reductive carboxylation for the cancer cells is that it decreases ROS levels and produces NADPH as a byproduct.</p></section><section id="Sec6" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Glutaminase isoenzymes can exert contrary functions</h3><p id="Par45" class="Para">As mentioned above, the first step of Gln degradation is catalyzed by glutaminase (GLA). The paralogous GLA isoenzymes are encoded by the <em class="EmphasisTypeItalic ">Gls</em> and the <em class="EmphasisTypeItalic ">Gls2</em> genes (reviewed by Campos-Sandoval et al. <span class="CitationRef"><a href="#CR11">2015</a></span>). These genes are linked to tumor behavior, because oncogenes and tumor suppressor genes regulate them. Interestingly, differential expression of GLA isoenzymes alters the metabolism of nutrients. In brain tumor settings, however, the exact role of GLA isoenzymes is unclear, because these isoenzymes can exert contrary functions. For example, silencing the <em class="EmphasisTypeItalic ">Gls</em> gene (GLS) in glioblastoma cells LN229 and SFxL inhibited growth, lowered survival ratios, and induced apoptosis. The growth inhibition was even stronger under oxidative stress. Similar observations were made when the liver-type <em class="EmphasisTypeItalic ">Gls2</em> gene was <em class="EmphasisTypeItalic ">over</em>expressed in T98G glioma cells (reviewed by Campos-Sandoval et al. <span class="CitationRef"><a href="#CR11">2015</a></span>).</p></section><section id="Sec7" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">IDH wt glioma cells release Glu</h3><div id="Par46" class="Para">In IDH wild-type (wt) gliomas, Glu synthesis is catalyzed by high levels of branched-chain amino acid transaminase 1 (BCAT1), which convert αKG into Glu (Tönjes et al. <span class="CitationRef"><a href="#CR63">2013</a></span>). The byproduct of this reaction is ammonia. When intracellular Glu levels rise, excessive Glu is released via the glutamine/cysteine antiporter System <em class="EmphasisTypeItalic ">x</em><span class="Stack"><sub>c</sub><sup>−</sup></span> (extensively reviewed by Lewerenz et al. <span class="CitationRef"><a href="#CR39">2013</a></span>) in exchange for cysteine (Cys; Fig. <span class="InternalRef"><a href="#Fig3">3</a></span>). This exchange is favorable for the cancer cells, because Cys is a major component of the antioxidant Glutathione (GSH), which in turn is an antagonist of reactive oxygen species (ROS). Elevated ROS levels trigger apoptosis; hence to antagonize ROS is important for cancer cell survival. There are external and internal causes for elevated ROS levels. The main external cause in GBM, radiotherapy, directly induces ROS through radiation. Internal causes of ROS lie in the altered metabolism itself. In cancer cells large amounts of glucose are oxidized in the TCA cycle, rendering the cell with superoxide anions as side products. These superoxide anions contribute to high ROS levels (Masui et al. <span class="CitationRef"><a href="#CR44">2014</a></span>). High levels of GSH enable cancer cells to evade the induction of apoptosis through induced ROS.<figure class="Figure" id="Fig3"><div class="MediaObject" id="MO3"><a href="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig3_HTML.gif" target="_blank" rel="noopener noreferrer"><span class="u-screenreader-only">Open image in new window</span><img src="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig3_HTML.gif" alt="" /></a></div><figcaption class="Caption" lang="en"><div class="CaptionContent"><span class="CaptionNumber">Fig. 3</span><p class="SimplePara">Overview of biochemical reactions for energy and lipid production in the cell. α-ketoglutarate (αKG) and glutamate (Glu) are in the center of pathways like glutaminolysis or reductive carboxylation. Mutant IDH1 changes the dynamics of metabolic processes in the cell and leads to accumulation of 2HG. 2HG in turn inhibits JHDMs and TET, which leads to a hypermethylated phenotype. Ac-CoA, acetyl-CoA; OAA, oxaloacetate; Gln, glutamine; Glu, glutamate; Cys, cysteine; αKG, α-ketoglutarate; Succ-CoA, succinyl-CoA; Fum, fumarate; Mal, malate; PDH, pyruvate dehydrogenase; ACL, ATP-citrate lyase; IDH, isocitrate dehydrogenase; αKGDH, α-ketoglutarate dehydrogenase; JHDMs, Jumonji domain-containing histone demethylases; TET, Ten-Eleven-Translocation</p></div></figcaption></figure></div></section><section id="Sec8" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Methionine–Cysteine double deprivation increases ROS levels in glioma cells</h3><p id="Par47" class="Para">Recently it was shown that deprivation of amino acids like methionine (Met) or Cys leads to induction of ROS, too. Met or Cys deprivation alone already resulted in decreased proliferation of cells of the glioma cell lines U87 and U251 (Liu et al. <span class="CitationRef"><a href="#CR41">2015</a></span>). Double deprivation had a synergistic effect.</p><p id="Par48" class="Para">When extracellular nutrient supply is scarce, autophagy enables the tumor cells to meet the demand for required amino acids and nucleotides. Also the induction of ROS can induce autophagy in cancer cells (reviewed by Bellot et al. <span class="CitationRef"><a href="#CR6">2013</a></span>). Liu et al. (<span class="CitationRef"><a href="#CR41">2015</a></span>) studied the effects of double deprivation on autophagy. Met–Cys double deprivation led to an increased abundance of the autophagy-related protein LC3-II and autophagosomes. Furthermore, inhibition of autophagy increased the sensitivity of glioma cells to double deprivation.</p><p id="Par49" class="Para">In vivo studies showed that glioma proliferation was lower in tumor-bearing mice that received a Met–Cys deprived diet compared to a standard diet. In addition, histologic examination of tumors from Met–Cys deprived mice showed signs of autophagy (Liu et al. <span class="CitationRef"><a href="#CR41">2015</a></span>).</p><p id="Par50" class="Para">The induction of ROS in cancer cells through Met–Cys double deprivation offers a potential additional therapy option that would enhance the ROS inducing effects of chemo- and radiotherapy.</p></section><section id="Sec9" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">High levels of extracellular Glu impair healthy cells in the tumor microenvironment</h3><p id="Par51" class="Para">The exchange of Glu for Cys is favorable for the cancer cell, but not for healthy cells in its vicinity, because Glu causes cell death in the tumor environment (Takano et al. <span class="CitationRef"><a href="#CR60">2001</a></span>; Ye and Sontheimer <span class="CitationRef"><a href="#CR79">1999</a></span>). High levels of extracellular Glu lead to an imbalance in the glutamate/glutamine cycle between astrocytes and neurons. The results can be astrocyte swelling, a block of astrocytic Glu uptake and neuronal cell death (Bak et al. <span class="CitationRef"><a href="#CR4">2006</a></span>; Jayakumar et al. <span class="CitationRef"><a href="#CR34">2006</a></span>; Albrecht et al. <span class="CitationRef"><a href="#CR1">2006</a></span>). The challenge for the astrocytes does not seem to be the origin of Glu, but the amount. Yao et al. (<span class="CitationRef"><a href="#CR78">2014</a></span>) showed that astrocytes were able to take up Glu that was released by glioma cells. In a co-culture of astrocytes and glioma cells with the ratio 1:1, Glu released by glioma cells was taken up by astrocytes and no neuronal damage was observed. In these cultures extracellular Glu levels were reduced to 1–5 μM (compared to +30 μM in single glioma culture). Glu uptake by astrocytes reduced glioma cell proliferation, and prevented neuronal death by Ca<sup>2+</sup> overload. These conditions might resemble the tumor environment at an early stage of tumor development. In late stage gliomas, the astrocyte to glioma cell ratio is more likely to be around 0.5:1 or smaller. In vitro this ratio led to an increase of extracellular Glu and ammonia levels, which resulted in a block of Glu uptake by astrocytes and cell death (Yao et al. <span class="CitationRef"><a href="#CR78">2014</a></span>).</p></section><section id="Sec10" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Block of system <em class="EmphasisTypeItalic ">x</em><span class="Stack"><sub>c</sub><sup>−</sup></span> has positive effects on cells in the tumor vicinity</h3><p id="Par52" class="Para">One approach to reduce the damaging effects of high extracellular Glu levels was to reduce the amount of secreted Glu by blocking the System <em class="EmphasisTypeItalic ">x</em><span class="Stack"><sub>c</sub><sup>−</sup></span> (Savaskan et al. <span class="CitationRef"><a href="#CR57">2008</a></span>). System <em class="EmphasisTypeItalic ">x</em><span class="Stack"><sub>c</sub><sup>−</sup></span> is composed of xCT and CD98 in human primary gliomas and tested cell lines. In vitro Glu secretion was successfully reduced by downregulation of xCT via small interfering RNA (siRNA), and with the selective xCT inhibitor S-4-CPG (Savaskan et al. <span class="CitationRef"><a href="#CR57">2008</a></span>). Reduction of xCT had no impact on morphology, cell cycle progression, ROS formation or proliferation Brain slices challenged with conditioned media from xCT-silenced cells showed significantly less cell death than the control with conditioned media from glioma cells. In vivo studies confirmed that inhibition of xCT through S-4-CPG reduced Glu secretion. That resulted in a lower neuronal damage, later onset of neurological deficits, and prolonged survival compared to the vehicle control group (Savaskan et al. <span class="CitationRef"><a href="#CR57">2008</a></span>).</p><p id="Par53" class="Para">Intracellular peaks of acetyl-CoA levels correlate with phases of growth and proliferation in the yeast metabolic cycle. Furthermore, the gene battery in yeast that is differentially acetylated during high acetyl-CoA levels corresponds to target genes of c-Myc in mammalian cells (Ji et al. <span class="CitationRef"><a href="#CR35">2011</a></span>). It has been concluded that acetyl-CoA levels directly influence epigenetic regulation through differential acetylation, which would describe an evolutionary conservative mechanism to link growth and proliferation to the nutritional state of the cell (Kaelin and McKnight <span class="CitationRef"><a href="#CR36">2013</a></span>; Masui et al. <span class="CitationRef"><a href="#CR44">2014</a></span>).</p></section></div></section><section id="Sec11" tabindex="-1" class="Section1 RenderAsSection1"><h2 class="Heading">Metabolic compensations to anti-tumor therapy</h2><div class="content"><p id="Par54" class="Para">Key cancer metabolites have been the target of anti-tumor therapies, but most single target approaches have failed, because cancer cells can compensate for disturbed pathways and lacking metabolites. Here, we give some examples of adaptions made by glioma cells to deletion or impairment of metabolic pathways.</p><section id="Sec12" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Increased synthesis of asparagine halts apoptotic pathway in glutamine-depleted glioma cells</h3><p id="Par55" class="Para">The non-essential amino acid Gln is, beside glucose, the most important energy source for glioma cells. Zhang et al. (<span class="CitationRef"><a href="#CR80">2014</a></span>) reported that Gln withdrawal led to apoptosis in SF188 human glioma cells with MYC amplification. That is somewhat surprising regarding the theoretical ability of the cell to synthesize Gln when sufficient amounts of glucose are available. Since Gln is crucial for asparagine (Asn) synthesis, it was tested if depletion of Asn has an effect on SF188 cells. Asn was depleted through knockdown of the enzyme asparagine synthetase (AS) that catalyzes the biosynthesis of Asn from aspartate and Gln. It has been reported that AS mRNA abundance is negatively correlated with glucose availability (Barbosa-Tessmann et al. <span class="CitationRef"><a href="#CR5">1999</a></span>). AS depletion led to apoptosis in SF188 cells (Zhang et al. <span class="CitationRef"><a href="#CR80">2014</a></span>). Addition of extracellular Asn completely restored survival and proliferation. These results are in line with the studies on the evasion of apoptosis through Asn in the case of sarcoma (Hettmer et al. <span class="CitationRef"><a href="#CR31">2015</a></span>), and human melanoma and epidermoid carcinoma cells (Li et al. <span class="CitationRef"><a href="#CR40">2015</a></span>). The authors conclude that Asn is crucial for cellular adaption to loss of Gln (Zhang et al. <span class="CitationRef"><a href="#CR80">2014</a></span>). In Asn-deficient cells, translation of stress response RNAs like CHOP leads to apoptosis. Asn alone was sufficient to stop the apoptotic function of ATF4 through regulation of a pathway that induces translation-dependent apoptosis. Intracellular depletion of Asn alone resulted in apoptosis independent of Glu or glucose availability (Zhang et al. <span class="CitationRef"><a href="#CR80">2014</a></span>).</p><p id="Par56" class="Para">Acute lymphoblastic leukemia (ALL) has been successfully treated through extracellular removal of Asn with <span class="EmphasisTypeSmallCaps ">l</span>-asparaginase (Avramis <span class="CitationRef"><a href="#CR2">2012</a></span>). Asparaginase (ASNase), an enzyme that hydrolyzes Asn, offers an option to deplete Asn intracellularly. Panosyan et al. (<span class="CitationRef"><a href="#CR49">2014</a></span>) showed that reduction of Asn through ASNase led to growth inhibition in DAOY medulloblastoma cells, GBM-ES cells, U87 cells, and mouse glioma (GL-261) cells in vitro. Gln addition increased Asn synthesis and abrogated the effect. Moreover, ASNase treatment affected the formation of neurospheres negatively.</p><p id="Par57" class="Para">Despite the promising in vitro results, ASNase-treated mice showed the same DAOY tumor growth as controls. Moreover, co-treatment with ASNase and temozolomide resulted in growth inhibition compared to temozolomide alone.</p></section><section id="Sec13" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Regulators of amino acid metabolism</h3><p id="Par58" class="Para">Crucial amino acids can be acquired in various ways. The example of Asn shows that they can derive from breakdown of metabolites like Glu, or they can be taken up from the extracellular matrix. A more common source of free amino acids in the cytosol is the degradation and breakdown of proteins and peptides. This recycling process occurs constantly in healthy and transformed cells and is orchestrated by proteasomes and aminopeptidases (Saric et al. <span class="CitationRef"><a href="#CR55">2004</a></span>). Aminopetidases such as serine aminopeptidase dipeptidyl peptidase (Busek et al. <span class="CitationRef"><a href="#CR10">2012</a></span>), leucine aminopeptidase 3 (He et al. <span class="CitationRef"><a href="#CR28">2015</a></span>) and methionine aminopeptidase 2 (Dasgupta et al. <span class="CitationRef"><a href="#CR16">2005</a></span>) play a role in glioma. However, no treatment that involves aminopeptidases has been proven to be effective in glioma. However, there is no effective aminopeptidase inhibitor registered, while those currently in clinical development have not yet been tested in glioma (Hitzerd et al. <span class="CitationRef"><a href="#CR33">2014</a></span>).</p><p id="Par59" class="Para">There are several approaches to inhibit the protein degradation pathway in cancer, such as E3 ubiquitin ligase inhibitors (Snoek et al. <span class="CitationRef"><a href="#CR58">2013</a></span>), proteasome inhibitors, and aminopeptidase inhibitors (reviewed by Hitzerd et al. <span class="CitationRef"><a href="#CR33">2014</a></span>). Some of these have been tested in clinical trials, or are clinically approved like the proteasome inhibitor bortezomib. Insights that were obtained in these trials could help to develop a specific strategy for glioma treatment.</p></section><section id="Sec14" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">mTOR inhibitors have not been proven effective in glioma therapy</h3><p id="Par60" class="Para">A central regulator of metabolism and cell growth is the kinase mechanistic target of rapamycin (or mammalian target of rapamycin; mTOR). mTOR is a downstream target of EGFR (epidermal growth factor receptor) through the PI3 K-Akt signaling pathway. 40 % of GBM have aberrant EGFR signaling; most carry the EGFRvIII mutant (Ekstrand et al. <span class="CitationRef"><a href="#CR19">1991</a></span>; Wong et al. <span class="CitationRef"><a href="#CR74">1992</a></span>). The mutant is characterized by a deletion of exons 2–7 of the <em class="EmphasisTypeItalic ">EGFR</em> gene, which results in an in-frame deletion of 267 amino acids from the extracellular domain of the receptor. EGFRvIII receptors are unable to bind growth factors, but are constitutively active in downstream signaling.</p><p id="Par61" class="Para">mTOR is found in two major complexes; mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Both complexes promote increased c-Myc activity. mTORC1 splices the MYC-interacting protein MAX, which enhances c-Myc action (Babic et al. <span class="CitationRef"><a href="#CR3">2013</a></span>). mTORC2 controls c-Myc levels in a FOXO-acetylation-dependent manner (Masui et al. <span class="CitationRef"><a href="#CR43">2013</a></span>). Overexpressed Myc is a strong oncogene and has been explored in multiple types of cancer including glioma and GBM. It has been shown that c-Myc negatively regulates the tumor suppressor gene <em class="EmphasisTypeItalic ">PTEN</em> (Guo et al. <span class="CitationRef"><a href="#CR26">2013</a></span>) and is involved in resistance to temozolomide therapy (Luo et al. <span class="CitationRef"><a href="#CR42">2015</a></span>). Besides these effects it is strongly involved in metabolic reprogramming in glioma. It enhances GLS activity, which leads to increased glutaminolysis, higher Glu production and possibly increased reductive carboxylation.</p><p id="Par62" class="Para">Targeted therapies with mTOR kinase inhibitors have not proven to be effective in glioma therapy. To elucidate underlying mechanisms, magnetic resonance spectroscopy (MRS) of 12 GBM patients was carried out (Tanaka et al. <span class="CitationRef"><a href="#CR61">2015</a></span>). The study indicated that Gln was strongly involved in metabolic reprogramming in GBM cells and the authors saw a connection between upregulation of Gln metabolism through increased GLS activity, and resistance to mTOR kinase inhibitors (Tanaka et al. <span class="CitationRef"><a href="#CR61">2015</a></span>). The results indicated that mTOR-targeted therapy led to increased Gln metabolism and rendered glioma cells Gln-dependent, which could be an approach for effective therapy options. Combinations of mTOR inhibitors with other drugs affecting signaling pathways may have promise for further development.</p><p id="Par63" class="Para">Another way to inhibit mTOR signaling is the use of aminopeptidase inhibitors. Compounds such as tosedostat or bestatin inhibit aminopeptidase, which results in lowering the free amino acid levels. This in turn decreases mTOR signaling (reviewed by Hitzerd et al. <span class="CitationRef"><a href="#CR33">2014</a></span>).</p></section></div></section><section id="Sec15" tabindex="-1" class="Section1 RenderAsSection1"><h2 class="Heading">Differences between IDH-wt and IDH-mutant gliomas</h2><div class="content"><p id="Par64" class="Para">Although <em class="EmphasisTypeItalic ">IDH</em> mutations often occur in gliomas, not all gliomas carry <em class="EmphasisTypeItalic ">IDH</em> mutations. The gain-of-function mutation shifts IDH activity. Its mutant IDH mediates the conversion of αKG into 2HG.</p><section id="Sec16" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Isocitrate dehydrogenase (IDH)</h3><p id="Par65" class="Para">One of the most exciting discoveries of the past years in the field of cancer metabolism was the one of IDH1/2 mutations in gliomas and acute myeloid leukemia (Dang et al. <span class="CitationRef"><a href="#CR15">2010</a></span>; Reitman and Yan <span class="CitationRef"><a href="#CR53">2010</a></span>). Only few mutations in genes that encode for metabolic enzymes are linked to tumor genesis. Examples for homozygous loss-of-function mutations in metabolic tumor suppressors are fumarate hydratase or one of the five subunits comprising the succinate dehydrogenase complex (King et al. <span class="CitationRef"><a href="#CR38">2006</a></span>). In contrast to these examples, heterozygous IDH mutations lead to a gain-of-function. Therefore, <em class="EmphasisTypeItalic ">IDH</em> is not a tumor suppressor gene.</p><p id="Par66" class="Para">Due to the great number of recent reviews on this topic (Guo et al. <span class="CitationRef"><a href="#CR25">2011</a></span>; van Lith et al. <span class="CitationRef"><a href="#CR66">2014</a></span>; Molenaar et al. <span class="CitationRef"><a href="#CR46">2014</a></span>; Bogdanovic <span class="CitationRef"><a href="#CR7">2015</a></span>; Borodovsky et al. 2015; Parker and Metallo <span class="CitationRef"><a href="#CR50">2015</a></span>), this report will be limited to a brief summary of main observations on <em class="EmphasisTypeItalic ">IDH</em> mutations and the consequence for cell metabolism in regard to Glu and αKG.</p></section><section id="Sec17" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">2-Hydroxyglutarate is an oncometabolite</h3><div id="Par67" class="Para">IDH enzymes catalyze the NADP<sup>+</sup>/NAD<sup>+</sup>-dependent conversion of isocitrate to 2HG (also known as 2-oxoglutarate; Zhao et al. <span class="CitationRef"><a href="#CR81">2009</a></span>). The cytoplasmic version of the enzyme, IDH1, acts in the cytoplasm; IDH2 and IDH3 act in mitochondria, mainly in the TCA cycle. 70–90 % of grades II and III glioma and secondary GBMs carry mutated <em class="EmphasisTypeItalic ">IDH1</em> or <em class="EmphasisTypeItalic ">IDH2</em> genes (Parsons et al. <span class="CitationRef"><a href="#CR51">2008</a></span>; Yan et al. <span class="CitationRef"><a href="#CR77">2009</a></span>). Mutations in the <em class="EmphasisTypeItalic ">IDH3</em> gene have not been reported in connection with tumors; therefore, in this article the term <em class="EmphasisTypeItalic ">IDH</em> mutation refers only to <em class="EmphasisTypeItalic ">IDH1</em> and <em class="EmphasisTypeItalic ">IDH2</em>. The most common amino acid substitution in glioma is the replacement of arginine with histidine in the <em class="EmphasisTypeItalic ">IDH1</em> gene (IDH1R132H; Parsons et al. <span class="CitationRef"><a href="#CR51">2008</a></span>; Yan et al. <span class="CitationRef"><a href="#CR77">2009</a></span>; Borger and Zhu <span class="CitationRef"><a href="#CR8">2012</a></span>; Hirata et al. <span class="CitationRef"><a href="#CR32">2015</a></span>, Table <span class="InternalRef"><a href="#Tab1">1</a></span>). In the case of IDH2, the substrate-binding arginine (Arg) residues Arg 140 and Arg 172 are mutated. In both cases the mutation results in a gain-of-function of the enzyme, which leads to an increased conversion of αKG to 2HG and subsequently to an accumulation of 2HG in the cell (Dang et al. <span class="CitationRef"><a href="#CR14">2009</a></span>; Gross et al. <span class="CitationRef"><a href="#CR24">2010</a></span>; Ward et al. <span class="CitationRef"><a href="#CR71">2010</a></span>). 2HG itself inhibits Ten-Eleven-Translocation (TET) family and Jumonji-C-domain-containing histone demethylases (JHDMs; Chowdhury et al. <span class="CitationRef"><a href="#CR13">2011</a></span>; Xu et al. <span class="CitationRef"><a href="#CR76">2011</a></span>; Fig. <span class="InternalRef"><a href="#Fig3">3</a></span>).<div id="Tab1" class="Table"><div class="Caption" lang="en"><div class="CaptionContent"><span class="CaptionNumber">Table 1</span><p class="SimplePara">Differences between wild-type and mutated IDH</p></div></div><div class="u-scroll-horizontal"><table><colgroup><col class="tcol1 align-left" /><col class="tcol2 align-left" /><col class="tcol3 align-left" /></colgroup><thead><tr><th> </th><th><p class="SimplePara">Wild-type <em class="EmphasisTypeItalic ">IDH</em></p></th><th><p class="SimplePara">Mutant <em class="EmphasisTypeItalic ">IDH</em></p></th></tr></thead><tbody><tr><td><p class="SimplePara">Heterozygous point mutations in the catalytic site</p></td><td><p class="SimplePara">None</p></td><td><p class="SimplePara">Arg to His in position 132 (<em class="EmphasisTypeItalic ">IDH1</em>, R132H)</p><p class="SimplePara">Arg in position 172 and 140 (<em class="EmphasisTypeItalic ">IDH2</em>)</p></td></tr><tr><td><p class="SimplePara">Substrate affinity</p></td><td><p class="SimplePara">Same affinity for isocitrate and α-ketoglutarate</p></td><td><p class="SimplePara">Lower affinity for isocitrate, higher affinity for α-ketoglutarate</p></td></tr><tr><td><p class="SimplePara">IDH-mediated reaction</p></td><td><p class="SimplePara">Isocitrate &lt;−&gt; <em class="EmphasisTypeItalic ">α</em>-ketoglutarate</p></td><td><p class="SimplePara">α-Ketoglutarate—&gt;2-hydroxyglutarate</p></td></tr><tr><td><p class="SimplePara">2-hydroxyglutarate levels</p></td><td><p class="SimplePara">Low</p></td><td><p class="SimplePara">High</p></td></tr></tbody></table></div></div></div><p id="Par68" class="Para">These enzymes are directly involved in demethylating processes in the genome. In that way high 2HG concentrations in the cell lead to global DNA hypermethylation and altered gene expression (Figueroa et al. <span class="CitationRef"><a href="#CR20">2010</a></span>; Sasaki et al. <span class="CitationRef"><a href="#CR56">2012</a></span>; Turcan et al. <span class="CitationRef"><a href="#CR65">2012</a></span>). Unsurprisingly there is a tight correlation between <em class="EmphasisTypeItalic ">IDH1</em> mutations and a hypermethylated phenotype named glioma-CpG island methylator phenotype (G-CIMP; Noushmehr et al. <span class="CitationRef"><a href="#CR48">2010</a></span>). Since these alterations provide the basis for cancer, 2HG is described as ‘oncometabolite’. The exciting fact about <em class="EmphasisTypeItalic ">IDH</em> mutations is that it seems likely that this metabolic alteration is more of a major contributor to cancer initiation and progression, than a mere side effect. This makes it a potential target for therapy. Inhibitors of mutant IDH1 have been effective in lowering 2HG levels in vivo (Popovici-Muller et al. <span class="CitationRef"><a href="#CR52">2012</a></span>) and reducing growth of glioma cells in vitro (Rohle et al. <span class="CitationRef"><a href="#CR54">2013</a></span>). However, there is more to IDH-mutant cancer cells than just a shift in levels of two metabolites.</p></section><section id="Sec18" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">αKG and Glu in IDH-mutant cancer cells</h3><div id="Par69" class="Para">αKG levels should be low in <em class="EmphasisTypeItalic ">IDH</em>-mutant cancer cells compared to <em class="EmphasisTypeItalic ">IDH</em> wt cells, due to increased conversion of αKG to 2HG. In fact they are relatively high, because mitochondrial biosynthesis makes up for missing cytoplasmic αKG (Van Lith et al. <span class="CitationRef"><a href="#CR66">2014</a></span>). That in turn influences the mitochondrial TCA cycle considerably (Table <span class="InternalRef"><a href="#Tab2">2</a></span>).<div id="Tab2" class="Table"><div class="Caption" lang="en"><div class="CaptionContent"><span class="CaptionNumber">Table 2</span><p class="SimplePara">Versatile effects of <em class="EmphasisTypeItalic ">IDH</em> mutations on cell metabolism</p></div></div><div class="u-scroll-horizontal"><table><colgroup><col class="tcol1 align-left" /><col class="tcol2 align-left" /><col class="tcol3 align-left" /></colgroup><thead><tr><th><p class="SimplePara">Alterations through <em class="EmphasisTypeItalic ">IDH</em> mutation</p></th><th><p class="SimplePara">Affected pathway</p></th><th><p class="SimplePara">Negative effect on</p></th></tr></thead><tbody><tr><td><p class="SimplePara">αKG to 2HG-conversion</p></td><td><p class="SimplePara">αKG–2HG</p></td><td><p class="SimplePara">NADPH production</p></td></tr><tr><td><p class="SimplePara">Increased 2HG levels</p></td><td><p class="SimplePara">αKG-2HG</p></td><td><p class="SimplePara">DNA methylation</p><p class="SimplePara">ATP synthesis</p></td></tr><tr><td rowspan="2"><p class="SimplePara">Increased need for cytoplasmic αKG</p></td><td><p class="SimplePara">Glu-αKG</p></td><td><p class="SimplePara">Glu export</p><p class="SimplePara">Cys import</p></td></tr><tr><td><p class="SimplePara">Mitochondrial malate–αKG antiporter</p></td><td><p class="SimplePara">αKG levels in mitochondria</p></td></tr><tr><td><p class="SimplePara">Reduced αKG availability</p></td><td><p class="SimplePara">Glutaminolysis</p></td><td><p class="SimplePara">ATP production</p></td></tr><tr><td><p class="SimplePara">Distorted conversion of αKG to isocitrate</p></td><td><p class="SimplePara">Reductive carboxylation</p></td><td><p class="SimplePara">Lipid synthesis</p></td></tr></tbody></table></div></div></div></section><section id="Sec19" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">Mutant IDH results in deployed lipid synthesis</h3><p id="Par70" class="Para">Increased synthesis of αKG through mitochondria means decreased levels of αKG substrates like citrate. Citrate, however, is crucial for acetly-CoA synthesis and therefore directly involved in the build-up of fatty acids. It is conceivable that the mutation of IDH leads to an altered ratio of fatty acid products like sphingolipids, or phospholipids. Although no data have been published on this matter, it has been claimed that <em class="EmphasisTypeItalic ">IDH1</em> mutations indirectly alter the levels of sphingomyelin in mouse brains (Bogdanovic <span class="CitationRef"><a href="#CR7">2015</a></span>).</p><div id="Par71" class="Para">As described earlier, IDH does not only assist the conversion of isocitrate to αKG, but also the reverse reaction during reductive carboxylation. In <em class="EmphasisTypeItalic ">IDH</em>-mutant tumors one would expect reductive carboxylation to be idle, due to the partial loss of IDH activity. Indeed, in hypoxic conditions heterozygous <em class="EmphasisTypeItalic ">IDH1</em>-mutant cells were impeded in their reductive carboxylation ability and increased their oxidative TCA metabolism (Table <span class="InternalRef"><a href="#Tab3">3</a></span>). <em class="EmphasisTypeItalic ">IDH2</em> mutant cells, however, continued to perform reductive carboxylation (Grassian et al. <span class="CitationRef"><a href="#CR23">2014</a></span>). It was shown that even an abundant amount of substrate for reductive carboxylation in <em class="EmphasisTypeItalic ">IDH1</em> mutant cells did not result in higher citrate levels, which suggest that the process itself is disrupted. <em class="EmphasisTypeItalic ">IDH1</em> mutant glioma cells might be sensitive to mitochondrial stress, because the <em class="EmphasisTypeItalic ">IDH1</em> mutation silences the cytoplasmic, Gln-dependent pathway for metabolites and fatty acids (Table <span class="InternalRef"><a href="#Tab3">3</a></span>).<div id="Tab3" class="Table"><div class="Caption" lang="en"><div class="CaptionContent"><span class="CaptionNumber">Table 3</span><p class="SimplePara">Lipids synthesis in cells with wild-type <em class="EmphasisTypeItalic ">IDH</em> and mutated <em class="EmphasisTypeItalic ">IDH</em> under different growth conditions</p></div></div><div class="u-scroll-horizontal"><table><colgroup><col class="tcol1 align-left" /><col class="tcol2 align-left" /><col class="tcol3 align-left" /></colgroup><thead><tr><th> </th><th><p class="SimplePara">Wild-type <em class="EmphasisTypeItalic ">IDH</em></p></th><th><p class="SimplePara">Mutant <em class="EmphasisTypeItalic ">IDH</em></p></th></tr></thead><tbody><tr><td><p class="SimplePara">IDH-mediated reaction</p></td><td><p class="SimplePara">Isocitrate &lt;−&gt; α-ketoglutarate</p></td><td><p class="SimplePara">α-ketoglutarate—&gt;2-hydroxyglutarate</p></td></tr><tr><td colspan="3"><p class="SimplePara">Lipid synthesis under</p></td></tr><tr><td><p class="SimplePara"> Normal conditions</p></td><td><p class="SimplePara">Good</p></td><td><p class="SimplePara">Good</p></td></tr><tr><td><p class="SimplePara">  Main substrate</p></td><td><p class="SimplePara"> Glucose</p></td><td><p class="SimplePara"> Glucose</p></td></tr><tr><td><p class="SimplePara">  Pathway</p></td><td><p class="SimplePara"> TCA cycle</p></td><td><p class="SimplePara"> TCA cycle</p></td></tr><tr><td><p class="SimplePara"> Hypoxic conditions</p></td><td><p class="SimplePara">Good</p></td><td><p class="SimplePara">Compromised</p></td></tr><tr><td><p class="SimplePara">  Main substrate</p></td><td><p class="SimplePara"> Glutamine</p></td><td><p class="SimplePara"> Glutamine</p></td></tr><tr><td><p class="SimplePara">  Pathway</p></td><td><p class="SimplePara"> IDH-mediated reversed flux</p></td><td><p class="SimplePara"> Disturbed reversed flux</p></td></tr><tr><td><p class="SimplePara"> Inhibited TCA metabolism</p></td><td><p class="SimplePara">Good</p></td><td><p class="SimplePara">Compromised</p></td></tr><tr><td><p class="SimplePara">  Main substrate</p></td><td><p class="SimplePara"> Glutamine</p></td><td><p class="SimplePara"> Glutamine</p></td></tr><tr><td><p class="SimplePara">  Pathway</p></td><td><p class="SimplePara"> IDH-mediated reversed flux</p></td><td><p class="SimplePara"> Disturbed reversed flux</p></td></tr></tbody></table></div></div></div></section><section id="Sec20" tabindex="-1" class="Section2 RenderAsSection2"><h3 class="Heading">IDH-mutant cells are susceptible to ROS-induced damage</h3><p id="Par72" class="Para">In cases of disrupted metabolic pathways, like an impeded TCA cycle, it is crucial for the cell to obtain a TCA cycle-independent source for αKG. Glu can easily be converted into αKG in the cytoplasm. Contrary to IDH wt glioma cells, IDH-mutant glioma cells do not release Glu on a large scale, because it is needed among others as substrate for the TCA cycle. Since IDH-mutant gliomas are “glutamate suckers” (Van Lith et al. <span class="CitationRef"><a href="#CR66">2014</a></span>), they cannot import much Cys through the system <em class="EmphasisTypeItalic ">x</em><span class="Stack"><sub>c</sub><sup>−</sup></span>. Therefore, they might have a lack of GSH. Together with low levels of NADPH this can result in a hampered resistance to ROS. Since Glu levels are strongly affiliated with Gln levels, IDH-mutant glioma cells also experience a high demand for Gln.</p><div id="Par73" class="Para">The IDH1-mediated conversion of αKG to isocitrate goes along with the conversion of NADPH to NADP<sup>+</sup>. The reversed reaction creates NADPH. Mutant IDH1, however, does not mediate reactions with isocitrate anymore. Instead it mediates the unidirectional conversion of αKG into 2HG with NADP<sup>+</sup> as abundant side product. Subsequently cytoplasmic production of NADPH or NADH, respectively, is decreased and available NADPH or NADH is consumed (Fig. <span class="InternalRef"><a href="#Fig4">4</a></span>). NADPH is the major metabolite to protect the cell from reactive oxygen species (ROS), because it is necessary to turn oxidized glutathione (GSSG) into reduced glutathione (GSH). GSH in turn directly neutralizes free radicals and ROS.<figure class="Figure" id="Fig4"><div class="MediaObject" id="MO4"><a href="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig4_HTML.gif" target="_blank" rel="noopener noreferrer"><span class="u-screenreader-only">Open image in new window</span><img src="https://static-content.springer.com/image/art%3A10.1007%2Fs00726-016-2342-9/MediaObjects/726_2016_2342_Fig4_HTML.gif" alt="" /></a></div><figcaption class="Caption" lang="en"><div class="CaptionContent"><span class="CaptionNumber">Fig. 4</span><p class="SimplePara">In <em class="EmphasisTypeItalic ">IDH1/2</em> wild-type cells, continuous NADPH production ensures low ROS levels (<em class="EmphasisTypeItalic ">left</em>). Mutant IDH1/2 activity consumes NADPH and lowers NADPH production. That results in increased ROS levels (<em class="EmphasisTypeItalic ">right</em>). <em class="EmphasisTypeItalic ">ROS</em> reactive oxygen species</p></div></figcaption></figure></div><p id="Par74" class="Para">As stated above, it is assumed that increased mitochondrial IDH2 activity makes up for cytoplasmic lack of αKG, which would increase NADPH availability. To what extent mitochondrial NADPH is transported to the cytoplasm remains to be elucidated. Whether the cancers with mutant <em class="EmphasisTypeItalic ">IDH</em> are more susceptible to ROS-induced stress (e.g., through radiation or temozolomide) is certainly dependent on the effects of the altered metabolism on the pentose phosphate pathway (PPP). The PPP is the major source of NADPH in the cytoplasm (Eggleston and Krebs <span class="CitationRef"><a href="#CR18">1974</a></span>), and has been linked to cancer metabolism (Tsouko et al. <span class="CitationRef"><a href="#CR64">2014</a></span>).</p></section></div></section><section id="Sec21" tabindex="-1" class="Section1 RenderAsSection1"><h2 class="Heading">2HG directly interferes with ATP synthase</h2><div class="content"><p id="Par75" class="Para">Besides the tumor-initiating effects, both enantiomers of 2HG have another substantial effect on cancer cell metabolism. 2HG and αKG are capable of binding directly to ATP synthase. In this way the enzyme is inhibited and cannot exert ATP synthesis anymore. That has negative effects on mitochondrial respiration and mTOR signaling in <em class="EmphasisTypeItalic ">ID-</em> mutant cancers (Fu et al. <span class="CitationRef"><a href="#CR22">2015</a></span>).</p></div></section><section id="Sec22" tabindex="-1" class="Section1 RenderAsSection1"><h2 class="Heading">Conclusion</h2><div class="content"><p id="Par76" class="Para">In this review we highlight that αKG and Glu are keystones in several crucial metabolic pathways. Next to glucose, Gln and αKG are important energy sources for the cancer cell. Especially in hypoxic conditions glutaminolysis and reductive carboxylation are needed to sustain cancer cell growth and proliferation. Glu and αKG are important links in the sequence of biochemical reactions. Furthermore, released Glu can have an impact on cells in the tumor vicinity, since high Glu levels lead to astrocytic swelling and apoptosis, which is believed to ease tumor expansion. Blockage of the efflux transporter System <em class="EmphasisTypeItalic ">x</em><span class="Stack"><sub>c</sub><sup>−</sup></span> abrogates the negative effect of glioma cells on their microenvironment. However, it does not hamper the glioma cells’ viability. Similarly, deprivation of amino acids has negative effects on cancer cells, but this is not sufficient to cause apoptosis. For example, Asn alone can block the apoptotic pathway on Glu-deprived glioma cells. Interestingly, when amino acids like Cys or Met are lacking in glioma cells, ROS levels increase. When it would be possible to push ROS levels over a critical limit, glioma proliferation would be inhibited. To achieve this, a combined approach of radiation, temozolomide and deprivation of amino acids and nutrients would be optimal. However, it is questionable if this is applicable in a clinical setting, without severely damaging healthy areas of the brain, regarding the neurotoxic side effects of anti-cancer drugs such as oxaliplatin, bortezomib, or epothilone-B (Ceresa et al. <span class="CitationRef"><a href="#CR12">2014</a></span>).</p><div id="Par77" class="Para">Recently a meta-study of 55 observational studies has shown that glioma patients with <em class="EmphasisTypeItalic ">IDH</em>-mutant tumors have a higher overall survival rate compared to <em class="EmphasisTypeItalic ">IDH</em>-wt tumors. Furthermore their progression-free survival is significantly increased (Xia et al. <span class="CitationRef"><a href="#CR75">2015</a></span>). This report is in line with reports of higher degrees of cell death in <em class="EmphasisTypeItalic ">IDH</em>-mutant gliomas. Regarding the reports about metabolic changes through <em class="EmphasisTypeItalic ">IDH</em> mutations, it seems natural that tumors with <em class="EmphasisTypeItalic ">IDH</em> mutations perform worse than <em class="EmphasisTypeItalic ">IDH</em>-wt tumors. Here we summarize the ways in which <em class="EmphasisTypeItalic ">IDH</em> mutations impede cellular metabolism:<div class="OrderedList"><ol><li class="ListItem"><span class="ItemNumber">1.</span><div class="ItemContent"><p id="Par78" class="Para">Mutant <em class="EmphasisTypeItalic ">IDH1</em> cannot perform reductive carboxylation to allow macromolecule synthesis in hypoxia.</p></div><div class="ClearBoth"> </div></li><li class="ListItem"><span class="ItemNumber">2.</span><div class="ItemContent"><p id="Par79" class="Para">Mutant <em class="EmphasisTypeItalic ">IDH</em> enzymes enhance the NADPH-dependent conversion of αKG to 2HG; leaving the cell with low NADPH levels and therefore more susceptible to stress through free radicals and ROS.</p></div><div class="ClearBoth"> </div></li><li class="ListItem"><span class="ItemNumber">3.</span><div class="ItemContent"><p id="Par80" class="Para">2HG directly inhibits ATP synthase by binding to it and leads to unfavorable effects under glucose restriction.</p></div><div class="ClearBoth"> </div></li></ol></div></div><p id="Par81" class="Para">It became apparent that especially hypoxic conditions are highly unfavorable for <em class="EmphasisTypeItalic ">IDH</em>-mutant cells. <em class="EmphasisTypeItalic ">IDH</em>-mutant cells might not be able to survive or at least proliferate in hypoxic conditions (Fig. <span class="InternalRef"><a href="#Fig3">3</a></span>). That would explain why IDH mutations are not common in solid tumors and only have been documented in diffuse forms of cancer like glioma or leukemia. In diffuse cancer types cells do not stay in close vicinity and therefore have fewer problems with oxygen supply.</p><p id="Par82" class="Para"><em class="EmphasisTypeItalic ">IDH</em> mutations play a large role in tumor onset. Later on, however, the malfunction of the IDH enzyme seems to challenge the cell more than it aids it. The metabolic alterations discussed in this article give a partial explanation at a molecular level for the effects of <em class="EmphasisTypeItalic ">IDH</em> mutations on overall survival that were reported in clinical studies. With regards to therapy approaches, it might be effective to enhance the problems the cell is confronted with by the mutant IDH enzyme.</p></div></section></div><section id="Notes" class="Section1 RenderAsSection1"><h2 class="Heading">Notes</h2><div class="content"><section><h3 class="Heading">Compliance with ethical standards</h3><div id="FPar1" class="FormalPara FormalParaRenderingStyle1"><h3 class="Heading">Conflict of interest</h3><p id="Par83" class="Para">The authors declare that they have no conflict of interest.</p></div><p class="SimplePara">This article does not contain any studies with human participants or animals performed by any of the authors. Hence no informed consent was required for any part of this review.</p></section></div></section><section class="Section1 RenderAsSection1" id="Bib1" tabindex="-1"><h3 class="Heading">References</h3><div class="content"><ol class="BibliographyWrapper"><li class="Citation"><div class="CitationContent" id="CR1">Albrecht J, Norenberg MD (2006) Glutamine: a trojan horse in ammonia neurotoxicity. Hepatology 44(4):788–794. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1002/hep.21357"><span class="RefSource">10.1002/hep.21357</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1002/hep.21357"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17006913"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Glutamine%3A%20a%20trojan%20horse%20in%20ammonia%20neurotoxicity&amp;author=J.%20Albrecht&amp;author=MD.%20Norenberg&amp;journal=Hepatology&amp;volume=44&amp;issue=4&amp;pages=788-794&amp;publication_year=2006&amp;doi=10.1002%2Fhep.21357"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR2">Avramis VI (2012) Asparaginases: biochemical pharmacology and modes of drug resistance. Anticancer Res 2438:2423–2437<span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Asparaginases%3A%20biochemical%20pharmacology%20and%20modes%20of%20drug%20resistance&amp;author=VI.%20Avramis&amp;journal=Anticancer%20Res&amp;volume=2438&amp;pages=2423-2437&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR3">Babic I, Anderson ES, Tanaka K et al (2013) EGFR mutation-induced alternative splicing of max contributes to growth of glycolytic tumors in brain cancer. Cell Metab 17(6):1000–1008. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2013.04.013"><span class="RefSource">10.1016/j.cmet.2013.04.013</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2013.04.013"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23707073"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679227"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=EGFR%20mutation-induced%20alternative%20splicing%20of%20max%20contributes%20to%20growth%20of%20glycolytic%20tumors%20in%20brain%20cancer&amp;author=I.%20Babic&amp;author=ES.%20Anderson&amp;author=K.%20Tanaka&amp;journal=Cell%20Metab&amp;volume=17&amp;issue=6&amp;pages=1000-1008&amp;publication_year=2013&amp;doi=10.1016%2Fj.cmet.2013.04.013"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR4">Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98(3):641–653. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1111/j.1471-4159.2006.03913.x"><span class="RefSource">10.1111/j.1471-4159.2006.03913.x</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1111/j.1471-4159.2006.03913.x"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16787421"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=The%20glutamate%2FGABA-glutamine%20cycle%3A%20aspects%20of%20transport%2C%20neurotransmitter%20homeostasis%20and%20ammonia%20transfer&amp;author=LK.%20Bak&amp;author=A.%20Schousboe&amp;author=HS.%20Waagepetersen&amp;journal=J%20Neurochem&amp;volume=98&amp;issue=3&amp;pages=641-653&amp;publication_year=2006&amp;doi=10.1111%2Fj.1471-4159.2006.03913.x"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR5">Barbosa-Tessmann IP, Pineda VL, Nick HS et al (1999) Transcriptional regulation of the human asparagine synthetase gene by carbohydrate availability. Biochem J 339(Pt 1):151–158. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1042/0264-6021%3A3390151"><span class="RefSource">10.1042/0264-6021:3390151</span></a></span>
                        <span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationContent" id="CR6">Bellot GL, Liu D, Pervaiz S (2013) ROS, autophagy, mitochondria and cancer: Ras, the hidden master? Mitochondrion 13(3):155–162. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.mito.2012.06.007"><span class="RefSource">10.1016/j.mito.2012.06.007</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.mito.2012.06.007"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22750269"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=ROS%2C%20autophagy%2C%20mitochondria%20and%20cancer%3A%20Ras%2C%20the%20hidden%20master%3F&amp;author=GL.%20Bellot&amp;author=D.%20Liu&amp;author=S.%20Pervaiz&amp;journal=Mitochondrion&amp;volume=13&amp;issue=3&amp;pages=155-162&amp;publication_year=2013&amp;doi=10.1016%2Fj.mito.2012.06.007"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR7">Bogdanovic E (2015) IDH1, lipid metabolism and cancer: shedding new light on old ideas. Biochim Biophys Acta Gen Subj 1850(9):1781–1785. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbagen.2015.04.014"><span class="RefSource">10.1016/j.bbagen.2015.04.014</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbagen.2015.04.014"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=IDH1%2C%20lipid%20metabolism%20and%20cancer%3A%20shedding%20new%20light%20on%20old%20ideas&amp;author=E.%20Bogdanovic&amp;journal=Biochim%20Biophys%20Acta%20Gen%20Subj&amp;volume=1850&amp;issue=9&amp;pages=1781-1785&amp;publication_year=2015&amp;doi=10.1016%2Fj.bbagen.2015.04.014"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR8">Borger DR, Zhu AX (2012) IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications. Expert Rev Anticancer Ther 12(5):543–546. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1586/era.12.32"><span class="RefSource">10.1586/era.12.32</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1586/era.12.32"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22594888"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=IDH%20mutations%3A%20new%20genetic%20signatures%20in%20cholangiocarcinoma%20and%20therapeutic%20implications&amp;author=DR.%20Borger&amp;author=AX.%20Zhu&amp;journal=Expert%20Rev%20Anticancer%20Ther&amp;volume=12&amp;issue=5&amp;pages=543-546&amp;publication_year=2012&amp;doi=10.1586%2Fera.12.32"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR9">Borodovsky A, Seltzer MJ, Riggins GJ (2012) Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2. Curr Opin Oncol 24(1):83–89. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1097/CCO.0b013e32834d816a"><span class="RefSource">10.1097/CCO.0b013e32834d816a</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1097/CCO.0b013e32834d816a"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22080945"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612588"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Altered%20cancer%20cell%20metabolism%20in%20gliomas%20with%20mutant%20IDH1%20or%20IDH2&amp;author=A.%20Borodovsky&amp;author=MJ.%20Seltzer&amp;author=GJ.%20Riggins&amp;journal=Curr%20Opin%20Oncol&amp;volume=24&amp;issue=1&amp;pages=83-89&amp;publication_year=2012&amp;doi=10.1097%2FCCO.0b013e32834d816a"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR10">Busek P, Stremenova J, Sromova L et al (2012) Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity. Int J Biochem Cell Biol 44(5):738–747. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.biocel.2012.01.011"><span class="RefSource">10.1016/j.biocel.2012.01.011</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.biocel.2012.01.011"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22306301"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Dipeptidyl%20peptidase-IV%20inhibits%20glioma%20cell%20growth%20independent%20of%20its%20enzymatic%20activity&amp;author=P.%20Busek&amp;author=J.%20Stremenova&amp;author=L.%20Sromova&amp;journal=Int%20J%20Biochem%20Cell%20Biol&amp;volume=44&amp;issue=5&amp;pages=738-747&amp;publication_year=2012&amp;doi=10.1016%2Fj.biocel.2012.01.011"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR11">Campos-Sandoval J, Martín-Rufián M, Cardona C et al (2015) Glutaminases in brain: multiple isoforms for many purposes. Neurochem Int 88:1–5. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.neuint.2015.03.006"><span class="RefSource">10.1016/j.neuint.2015.03.006</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.neuint.2015.03.006"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25837287"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Glutaminases%20in%20brain%3A%20multiple%20isoforms%20for%20many%20purposes&amp;author=J.%20Campos-Sandoval&amp;author=M.%20Mart%C3%ADn-Rufi%C3%A1n&amp;author=C.%20Cardona&amp;journal=Neurochem%20Int&amp;volume=88&amp;pages=1-5&amp;publication_year=2015&amp;doi=10.1016%2Fj.neuint.2015.03.006"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR12">Ceresa C, Avan A, Giovannetti E et al (2014) Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B. Anticancer Res 34(1):517–523. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1017/CBO9781107415324.004"><span class="RefSource">10.1017/CBO9781107415324.004</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24403510"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Characterization%20of%20and%20protection%20from%20neurotoxicity%20induced%20by%20oxaliplatin%2C%20bortezomib%20and%20epothilone-B&amp;author=C.%20Ceresa&amp;author=A.%20Avan&amp;author=E.%20Giovannetti&amp;journal=Anticancer%20Res&amp;volume=34&amp;issue=1&amp;pages=517-523&amp;publication_year=2014&amp;doi=10.1017%2FCBO9781107415324.004"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR13">Chowdhury R, Yeoh KK, Tian Y-M et al (2011) The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 12(5):463–469. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/embor.2011.43"><span class="RefSource">10.1038/embor.2011.43</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/embor.2011.43"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21460794"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090014"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=The%20oncometabolite%202-hydroxyglutarate%20inhibits%20histone%20lysine%20demethylases&amp;author=R.%20Chowdhury&amp;author=KK.%20Yeoh&amp;author=Y-M.%20Tian&amp;journal=EMBO%20Rep&amp;volume=12&amp;issue=5&amp;pages=463-469&amp;publication_year=2011&amp;doi=10.1038%2Fembor.2011.43"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR14">Dang L, White DW, Gross S et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274):739–744. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature08617"><span class="RefSource">10.1038/nature08617</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature08617"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19935646"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818760"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Cancer-associated%20IDH1%20mutations%20produce%202-hydroxyglutarate&amp;author=L.%20Dang&amp;author=DW.%20White&amp;author=S.%20Gross&amp;journal=Nature&amp;volume=462&amp;issue=7274&amp;pages=739-744&amp;publication_year=2009&amp;doi=10.1038%2Fnature08617"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR15">Dang L, Jin S, Su SM (2010) IDH mutations in glioma and acute myeloid leukemia. Trends Mol Med 16(9):387–397. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1017/CBO9781107415324.004"><span class="RefSource">10.1017/CBO9781107415324.004</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.molmed.2010.07.002"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20692206"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=IDH%20mutations%20in%20glioma%20and%20acute%20myeloid%20leukemia&amp;author=L.%20Dang&amp;author=S.%20Jin&amp;author=SM.%20Su&amp;journal=Trends%20Mol%20Med&amp;volume=16&amp;issue=9&amp;pages=387-397&amp;publication_year=2010&amp;doi=10.1017%2FCBO9781107415324.004"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR16">Dasgupta B, Yi Y, Hegedus B et al (2005) Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Cancer Res 65(21):9843–9850. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1158/0008-5472.CAN-05-1842"><span class="RefSource">10.1158/0008-5472.CAN-05-1842</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1158/0008-5472.CAN-05-1842"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16267007"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Cerebrospinal%20fluid%20proteomic%20analysis%20reveals%20dysregulation%20of%20methionine%20aminopeptidase-2%20expression%20in%20human%20and%20mouse%20neurofibromatosis%201-associated%20glioma&amp;author=B.%20Dasgupta&amp;author=Y.%20Yi&amp;author=B.%20Hegedus&amp;journal=Cancer%20Res&amp;volume=65&amp;issue=21&amp;pages=9843-9850&amp;publication_year=2005&amp;doi=10.1158%2F0008-5472.CAN-05-1842"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR17">DeBerardinis RJ, Cheng T (2010) Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29(3):313–324. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/onc.2009.358"><span class="RefSource">10.1038/onc.2009.358</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/onc.2009.358"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19881548"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Q%E2%80%99s%20next%3A%20the%20diverse%20functions%20of%20glutamine%20in%20metabolism%2C%20cell%20biology%20and%20cancer&amp;author=RJ.%20DeBerardinis&amp;author=T.%20Cheng&amp;journal=Oncogene&amp;volume=29&amp;issue=3&amp;pages=313-324&amp;publication_year=2010&amp;doi=10.1038%2Fonc.2009.358"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR18">Eggleston LV, Krebs H (1974) Regulation of the pentose phosphate cycle. Biochem J 138(3):425–435<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1042/bj1380425"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4154743"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1166228"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Regulation%20of%20the%20pentose%20phosphate%20cycle&amp;author=LV.%20Eggleston&amp;author=H.%20Krebs&amp;journal=Biochem%20J&amp;volume=138&amp;issue=3&amp;pages=425-435&amp;publication_year=1974"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR19">Ekstrand AJ, James CD, Cavenee WK et al (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:2164–2172<span class="Occurrences"><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2009534"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Genes%20for%20epidermal%20growth%20factor%20receptor%2C%20transforming%20growth%20factor%20alpha%2C%20and%20epidermal%20growth%20factor%20and%20their%20expression%20in%20human%20gliomas%20in%20vivo&amp;author=AJ.%20Ekstrand&amp;author=CD.%20James&amp;author=WK.%20Cavenee&amp;journal=Cancer%20Res&amp;volume=51&amp;pages=2164-2172&amp;publication_year=1991"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR20">Figueroa ME, Abdel-Wahab O, Lu C et al (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18(6):553–567. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.11.015"><span class="RefSource">10.1016/j.ccr.2010.11.015</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.11.015"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21130701"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105845"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Leukemic%20IDH1%20and%20IDH2%20mutations%20result%20in%20a%20hypermethylation%20phenotype%2C%20disrupt%20TET2%20function%2C%20and%20impair%20hematopoietic%20differentiation&amp;author=ME.%20Figueroa&amp;author=O.%20Abdel-Wahab&amp;author=C.%20Lu&amp;journal=Cancer%20Cell&amp;volume=18&amp;issue=6&amp;pages=553-567&amp;publication_year=2010&amp;doi=10.1016%2Fj.ccr.2010.11.015"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR21">Filipp FV, Scott DA, Ronai Z et al (2012) Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells. Pigment Cell Melanoma Res 25:375–383. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1111/j.1755-148X.2011.00997.x"><span class="RefSource">10.1111/j.1755-148X.2011.00997.x</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1111/j.1755-148X.2012.00989.x"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22360810"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329592"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Reverse%20TCA%20cycle%20flux%20through%20isocitrate%20dehydrogenases%201%20and%202%20is%20required%20for%20lipogenesis%20in%20hypoxic%20melanoma%20cells&amp;author=FV.%20Filipp&amp;author=DA.%20Scott&amp;author=Z.%20Ronai&amp;journal=Pigment%20Cell%20Melanoma%20Res&amp;volume=25&amp;pages=375-383&amp;publication_year=2012&amp;doi=10.1111%2Fj.1755-148X.2011.00997.x"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR22">Fu X, Chin RM, Vergnes L et al (2015) 2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling. Cell Metab 22(3):508–515. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2015.06.009"><span class="RefSource">10.1016/j.cmet.2015.06.009</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2015.06.009"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26190651"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663076"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=2-Hydroxyglutarate%20inhibits%20ATP%20synthase%20and%20mTOR%20signaling&amp;author=X.%20Fu&amp;author=RM.%20Chin&amp;author=L.%20Vergnes&amp;journal=Cell%20Metab&amp;volume=22&amp;issue=3&amp;pages=508-515&amp;publication_year=2015&amp;doi=10.1016%2Fj.cmet.2015.06.009"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR23">Grassian AR, Parker SJ, Davidson SM et al (2014) IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Res 74(12):3317–3331. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1158/0008-5472.CAN-14-0772-T"><span class="RefSource">10.1158/0008-5472.CAN-14-0772-T</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1158/0008-5472.CAN-14-0772-T"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24755473"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885639"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=IDH1%20mutations%20alter%20citric%20acid%20cycle%20metabolism%20and%20increase%20dependence%20on%20oxidative%20mitochondrial%20metabolism&amp;author=AR.%20Grassian&amp;author=SJ.%20Parker&amp;author=SM.%20Davidson&amp;journal=Cancer%20Res&amp;volume=74&amp;issue=12&amp;pages=3317-3331&amp;publication_year=2014&amp;doi=10.1158%2F0008-5472.CAN-14-0772-T"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR24">Gross S, Cairns RA, Minden MD et al (2010) Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 207(2):339–344. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1084/jem.20092506"><span class="RefSource">10.1084/jem.20092506</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1084/jem.20092506"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20142433"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822606"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Cancer-associated%20metabolite%202-hydroxyglutarate%20accumulates%20in%20acute%20myelogenous%20leukemia%20with%20isocitrate%20dehydrogenase%201%20and%202%20mutations&amp;author=S.%20Gross&amp;author=RA.%20Cairns&amp;author=MD.%20Minden&amp;journal=J%20Exp%20Med&amp;volume=207&amp;issue=2&amp;pages=339-344&amp;publication_year=2010&amp;doi=10.1084%2Fjem.20092506"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR25">Guo C, Pirozzi CJ, Lopez GY et al (2011) Isocitrate dehydrogenase mutations in gliomas. Curr Opin Neurol 24(6):648–652. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1097/WCO.0b013e32834cd415"><span class="RefSource">10.1097/WCO.0b013e32834cd415</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1097/WCO.0b013e32834cd415"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22002076"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640434"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Isocitrate%20dehydrogenase%20mutations%20in%20gliomas&amp;author=C.%20Guo&amp;author=CJ.%20Pirozzi&amp;author=GY.%20Lopez&amp;journal=Curr%20Opin%20Neurol&amp;volume=24&amp;issue=6&amp;pages=648-652&amp;publication_year=2011&amp;doi=10.1097%2FWCO.0b013e32834cd415"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR26">Guo P, Nie Q, Lan J et al (2013) C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells. Biochem Biophys Res Commun. 441(1):186–190. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbrc.2013.10.034"><span class="RefSource">10.1016/j.bbrc.2013.10.034</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbrc.2013.10.034"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24140063"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=C-Myc%20negatively%20controls%20the%20tumor%20suppressor%20PTEN%20by%20upregulating%20miR-26a%20in%20glioblastoma%20multiforme%20cells&amp;author=P.%20Guo&amp;author=Q.%20Nie&amp;author=J.%20Lan&amp;journal=Biochem%20Biophys%20Res%20Commun.&amp;volume=441&amp;issue=1&amp;pages=186-190&amp;publication_year=2013&amp;doi=10.1016%2Fj.bbrc.2013.10.034"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR27">Hanahan D, Weinberg R (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cell.2011.02.013"><span class="RefSource">10.1016/j.cell.2011.02.013</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cell.2011.02.013"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21376230"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Hallmarks%20of%20cancer%3A%20the%20next%20generation&amp;author=D.%20Hanahan&amp;author=R.%20Weinberg&amp;journal=Cell&amp;volume=144&amp;issue=5&amp;pages=646-674&amp;publication_year=2011&amp;doi=10.1016%2Fj.cell.2011.02.013"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR28">He X, Huang Q, Qiu X et al (2015) LAP3 promotes glioma progression by regulating proliferation, migration and invasion of glioma cells. Int J Biol Macromol 72:1081–1089. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ijbiomac.2014.10.021"><span class="RefSource">10.1016/j.ijbiomac.2014.10.021</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ijbiomac.2014.10.021"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25453285"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=LAP3%20promotes%20glioma%20progression%20by%20regulating%20proliferation%2C%20migration%20and%20invasion%20of%20glioma%20cells&amp;author=X.%20He&amp;author=Q.%20Huang&amp;author=X.%20Qiu&amp;journal=Int%20J%20Biol%20Macromol&amp;volume=72&amp;pages=1081-1089&amp;publication_year=2015&amp;doi=10.1016%2Fj.ijbiomac.2014.10.021"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR29">Hertz L (1979) Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters. Prog Neurobiol 13:277–323. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/0301-0082(79)90018-2"><span class="RefSource">10.1016/0301-0082(79)90018-2</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/0301-0082(79)90018-2"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=42117"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Functional%20interactions%20between%20neurons%20and%20astrocytes%20I.%20Turnover%20and%20metabolism%20of%20putative%20amino%20acid%20transmitters&amp;author=L.%20Hertz&amp;journal=Prog%20Neurobiol&amp;volume=13&amp;pages=277-323&amp;publication_year=1979&amp;doi=10.1016%2F0301-0082%2879%2990018-2"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR30">Hertz L, Dringen R, Schousboe A et al (1999) Astrocytes: glutamate producers for neurons. J Neurosci Res 57(4):417–428. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1002/(SICI)1097-4547(19990815)57%3A4%3c417%3AAID-JNR1%3e3.0.CO%3B2-N"><span class="RefSource">10.1002/(SICI)1097-4547(19990815)57:4&lt;417:AID-JNR1&gt;3.0.CO;2-N</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1002/(SICI)1097-4547(19990815)57%3A4&lt;417%3A%3AAID-JNR1&gt;3.0.CO%3B2-N"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10440891"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Astrocytes%3A%20glutamate%20producers%20for%20neurons&amp;author=L.%20Hertz&amp;author=R.%20Dringen&amp;author=A.%20Schousboe&amp;journal=J%20Neurosci%20Res&amp;volume=57&amp;issue=4&amp;pages=417-428&amp;publication_year=1999&amp;doi=10.1002%2F%28SICI%291097-4547%2819990815%2957%3A4%3C417%3A%3AAID-JNR1%3E3.0.CO%3B2-N"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR31">Hettmer S, Schinzel AC, Tchessalova D et al (2015) Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. Elife 4:e09436<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.7554/eLife.09436"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26499495"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695385"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Functional%20genomic%20screening%20reveals%20asparagine%20dependence%20as%20a%20metabolic%20vulnerability%20in%20sarcoma&amp;author=S.%20Hettmer&amp;author=AC.%20Schinzel&amp;author=D.%20Tchessalova&amp;journal=Elife&amp;volume=4&amp;pages=e09436&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR32">Hirata M, Sasaki M, Cairns RA et al (2015) Mutant IDH is sufficient to initiate enchondromatosis in mice. Proc Natl Acad Sci USA 112(9):2829–34. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1073/pnas.1424400112"><span class="RefSource">10.1073/pnas.1424400112</span></a></span>
                        <span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationContent" id="CR33">Hitzerd SM, Verbrugge SE, Ossenkoppele G et al (2014) Positioning of aminopeptidase inhibitors in next generation cancer therapy. Amino Acids 46(4):793–808. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1007/s00726-013-1648-0"><span class="RefSource">10.1007/s00726-013-1648-0</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1007/s00726-013-1648-0"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24385243"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Positioning%20of%20aminopeptidase%20inhibitors%20in%20next%20generation%20cancer%20therapy&amp;author=SM.%20Hitzerd&amp;author=SE.%20Verbrugge&amp;author=G.%20Ossenkoppele&amp;journal=Amino%20Acids&amp;volume=46&amp;issue=4&amp;pages=793-808&amp;publication_year=2014&amp;doi=10.1007%2Fs00726-013-1648-0"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR34">Jayakumar AR, Panickar KS, Murthy CRK et al (2006) Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes–Jayakumar et al. 26 (18):4774. J Neurosci 26(18):4774–4784. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1523/JNEUROSCI.0120-06.2006"><span class="RefSource">10.1523/JNEUROSCI.0120-06.2006</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1523/JNEUROSCI.0120-06.2006"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16672650"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Oxidative%20stress%20and%20mitogen-activated%20protein%20kinase%20phosphorylation%20mediate%20ammonia-induced%20cell%20swelling%20and%20glutamate%20uptake%20inhibition%20in%20cultured%20astrocytes%E2%80%93Jayakumar%20et%20al.%2026%20%2818%29%3A4774&amp;author=AR.%20Jayakumar&amp;author=KS.%20Panickar&amp;author=CRK.%20Murthy&amp;journal=J%20Neurosci&amp;volume=26&amp;issue=18&amp;pages=4774-4784&amp;publication_year=2006&amp;doi=10.1523%2FJNEUROSCI.0120-06.2006"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR35">Ji H, Wu G, Zhan X et al (2011) Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS One 6(10). doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1371/journal.pone.0026057"><span class="RefSource">10.1371/journal.pone.0026057</span></a></span>
                        <span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationContent" id="CR36">Kaelin WG, McKnight SL (2013) Influence of metabolism on epigenetics and disease. Cell 153(1):56–69. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cell.2013.03.004"><span class="RefSource">10.1016/j.cell.2013.03.004</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cell.2013.03.004"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23540690"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775362"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Influence%20of%20metabolism%20on%20epigenetics%20and%20disease&amp;author=WG.%20Kaelin&amp;author=SL.%20McKnight&amp;journal=Cell&amp;volume=153&amp;issue=1&amp;pages=56-69&amp;publication_year=2013&amp;doi=10.1016%2Fj.cell.2013.03.004"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR37">Kim JW, Tchernyshyov I, Semenza GL et al (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3(3):177–185. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2006.02.002"><span class="RefSource">10.1016/j.cmet.2006.02.002</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2006.02.002"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16517405"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=HIF-1-mediated%20expression%20of%20pyruvate%20dehydrogenase%20kinase%3A%20a%20metabolic%20switch%20required%20for%20cellular%20adaptation%20to%20hypoxia&amp;author=JW.%20Kim&amp;author=I.%20Tchernyshyov&amp;author=GL.%20Semenza&amp;journal=Cell%20Metab&amp;volume=3&amp;issue=3&amp;pages=177-185&amp;publication_year=2006&amp;doi=10.1016%2Fj.cmet.2006.02.002"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR38">King A, Selak M, Gottlieb E (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25(34):4675–4682. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/sj.onc.1209594"><span class="RefSource">10.1038/sj.onc.1209594</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/sj.onc.1209594"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16892081"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Succinate%20dehydrogenase%20and%20fumarate%20hydratase%3A%20linking%20mitochondrial%20dysfunction%20and%20cancer&amp;author=A.%20King&amp;author=M.%20Selak&amp;author=E.%20Gottlieb&amp;journal=Oncogene&amp;volume=25&amp;issue=34&amp;pages=4675-4682&amp;publication_year=2006&amp;doi=10.1038%2Fsj.onc.1209594"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR39">Lewerenz J, Hewett SJ, Huang Y et al (2013) The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18(5):522–555. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1089/ars.2011.4391"><span class="RefSource">10.1089/ars.2011.4391</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1089/ars.2011.4391"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22667998"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545354"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=The%20cystine%2Fglutamate%20antiporter%20system%20x%28c%29%28-%29%20in%20health%20and%20disease%3A%20from%20molecular%20mechanisms%20to%20novel%20therapeutic%20opportunities&amp;author=J.%20Lewerenz&amp;author=SJ.%20Hewett&amp;author=Y.%20Huang&amp;journal=Antioxid%20Redox%20Signal&amp;volume=18&amp;issue=5&amp;pages=522-555&amp;publication_year=2013&amp;doi=10.1089%2Fars.2011.4391"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR40">Li H, Zhou F, Du W et al (2015) Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells. Biotechnol Appl Biochem 1–6. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1002/bab.1383"><span class="RefSource">10.1002/bab.1383</span></a></span>
                        <span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationContent" id="CR41">Liu H, Zhang W, Wang K et al (2015) Methionine and cystine double deprivation stress suppresses glioma proliferation via inducing ROS/autophagy. Toxicol Lett 232(2):349–355. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.toxlet.2014.11.011"><span class="RefSource">10.1016/j.toxlet.2014.11.011</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.toxlet.2014.11.011"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25448282"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Methionine%20and%20cystine%20double%20deprivation%20stress%20suppresses%20glioma%20proliferation%20via%20inducing%20ROS%2Fautophagy&amp;author=H.%20Liu&amp;author=W.%20Zhang&amp;author=K.%20Wang&amp;journal=Toxicol%20Lett&amp;volume=232&amp;issue=2&amp;pages=349-355&amp;publication_year=2015&amp;doi=10.1016%2Fj.toxlet.2014.11.011"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR42">Luo H, Chen Z, Wang S et al (2015) C-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma. Brain 138(12):3654–3672. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1093/brain/awv287"><span class="RefSource">10.1093/brain/awv287</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1093/brain/awv287"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26450587"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=C-Myc-miR-29c-REV3L%20signalling%20pathway%20drives%20the%20acquisition%20of%20temozolomide%20resistance%20in%20glioblastoma&amp;author=H.%20Luo&amp;author=Z.%20Chen&amp;author=S.%20Wang&amp;journal=Brain&amp;volume=138&amp;issue=12&amp;pages=3654-3672&amp;publication_year=2015&amp;doi=10.1093%2Fbrain%2Fawv287"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR43">Masui K, Tanaka K, Akhavan D et al (2013) MTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab 18(5):726–739. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2013.09.013"><span class="RefSource">10.1016/j.cmet.2013.09.013</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.cmet.2013.09.013"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24140020"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=MTOR%20complex%202%20controls%20glycolytic%20metabolism%20in%20glioblastoma%20through%20FoxO%20acetylation%20and%20upregulation%20of%20c-Myc&amp;author=K.%20Masui&amp;author=K.%20Tanaka&amp;author=D.%20Akhavan&amp;journal=Cell%20Metab&amp;volume=18&amp;issue=5&amp;pages=726-739&amp;publication_year=2013&amp;doi=10.1016%2Fj.cmet.2013.09.013"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR44">Masui K, Cavenee WK, Mischel PS (2014) MTORC2 in the center of cancer metabolic reprogramming. Trends Endocrinol Metab 25(7):364–373. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.tem.2014.04.002"><span class="RefSource">10.1016/j.tem.2014.04.002</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.tem.2014.04.002"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24856037"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077930"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=MTORC2%20in%20the%20center%20of%20cancer%20metabolic%20reprogramming&amp;author=K.%20Masui&amp;author=WK.%20Cavenee&amp;author=PS.%20Mischel&amp;journal=Trends%20Endocrinol%20Metab&amp;volume=25&amp;issue=7&amp;pages=364-373&amp;publication_year=2014&amp;doi=10.1016%2Fj.tem.2014.04.002"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR45">Metallo CM, Gameiro PA, Bell EL et al (2012) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. TL - 481. Nature 481VN-(7381):380–384. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature10602"><span class="RefSource">10.1038/nature10602</span></a></span>
                        <span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationContent" id="CR46">Molenaar RJ, Radivoyevitch T, Maciejewski JP et al (2014) The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation. Biochim Biophys Acta 1846(2):326–341. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbcan.2014.05.004"><span class="RefSource">10.1016/j.bbcan.2014.05.004</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24880135"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=The%20driver%20and%20passenger%20effects%20of%20isocitrate%20dehydrogenase%201%20and%202%20mutations%20in%20oncogenesis%20and%20survival%20prolongation&amp;author=RJ.%20Molenaar&amp;author=T.%20Radivoyevitch&amp;author=JP.%20Maciejewski&amp;journal=Biochim%20Biophys%20Acta&amp;volume=1846&amp;issue=2&amp;pages=326-341&amp;publication_year=2014&amp;doi=10.1016%2Fj.bbcan.2014.05.004"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR47">Mullen AR, Wheaton WW, Jin ES et al (2012) Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481(7381):385–388. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature10642"><span class="RefSource">10.1038/nature10642</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Reductive%20carboxylation%20supports%20growth%20in%20tumour%20cells%20with%20defective%20mitochondria&amp;author=AR.%20Mullen&amp;author=WW.%20Wheaton&amp;author=ES.%20Jin&amp;journal=Nature&amp;volume=481&amp;issue=7381&amp;pages=385-388&amp;publication_year=2012&amp;doi=10.1038%2Fnature10642"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR48">Noushmehr H, Weisenberger DJ, Diefes K et al (2010) Identification of a CpG Island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5):510–522. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.03.017"><span class="RefSource">10.1016/j.ccr.2010.03.017</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.03.017"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20399149"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872684"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Identification%20of%20a%20CpG%20Island%20methylator%20phenotype%20that%20defines%20a%20distinct%20subgroup%20of%20glioma&amp;author=H.%20Noushmehr&amp;author=DJ.%20Weisenberger&amp;author=K.%20Diefes&amp;journal=Cancer%20Cell&amp;volume=17&amp;issue=5&amp;pages=510-522&amp;publication_year=2010&amp;doi=10.1016%2Fj.ccr.2010.03.017"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR49">Panosyan EH, Wang Y, Xia P et al (2014) Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors. Mol Cancer Res 12(5):694–702. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1158/1541-7786.MCR-13-0576"><span class="RefSource">10.1158/1541-7786.MCR-13-0576</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1158/1541-7786.MCR-13-0576"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24505127"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020976"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Asparagine%20depletion%20potentiates%20the%20cytotoxic%20effect%20of%20chemotherapy%20against%20brain%20tumors&amp;author=EH.%20Panosyan&amp;author=Y.%20Wang&amp;author=P.%20Xia&amp;journal=Mol%20Cancer%20Res&amp;volume=12&amp;issue=5&amp;pages=694-702&amp;publication_year=2014&amp;doi=10.1158%2F1541-7786.MCR-13-0576"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR50">Parker SJ, Metallo CM (2015) Metabolic consequences of oncogenic IDH mutations. Pharmacol Ther 152:54–62. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.pharmthera.2015.05.003"><span class="RefSource">10.1016/j.pharmthera.2015.05.003</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.pharmthera.2015.05.003"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25956465"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489982"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Metabolic%20consequences%20of%20oncogenic%20IDH%20mutations&amp;author=SJ.%20Parker&amp;author=CM.%20Metallo&amp;journal=Pharmacol%20Ther&amp;volume=152&amp;pages=54-62&amp;publication_year=2015&amp;doi=10.1016%2Fj.pharmthera.2015.05.003"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR51">Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 2008(1807):1807–1812. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1126/science.1164382"><span class="RefSource">10.1126/science.1164382</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1126/science.1164382"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=An%20integrated%20genomic%20analysis%20of%20human%20glioblastoma%20multiforme&amp;author=DW.%20Parsons&amp;author=S.%20Jones&amp;author=X.%20Zhang&amp;journal=Science&amp;volume=2008&amp;issue=1807&amp;pages=1807-1812&amp;publication_year=2008&amp;doi=10.1126%2Fscience.1164382"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR52">Popovici-Muller J, Saunders JO, Salituro FG et al (2012) Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo. ACS Med Chem Lett 3(10):850–855. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1021/ml300225h"><span class="RefSource">10.1021/ml300225h</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1021/ml300225h"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24900389"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025665"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Discovery%20of%20the%20first%20potent%20inhibitors%20of%20mutant%20IDH1%20that%20lower%20tumor%202-HG%20in%20vivo&amp;author=J.%20Popovici-Muller&amp;author=JO.%20Saunders&amp;author=FG.%20Salituro&amp;journal=ACS%20Med%20Chem%20Lett&amp;volume=3&amp;issue=10&amp;pages=850-855&amp;publication_year=2012&amp;doi=10.1021%2Fml300225h"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR53">Reitman ZJ, Yan H (2010) Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst 102(13):932–941. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1093/jnci/djq187"><span class="RefSource">10.1093/jnci/djq187</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1093/jnci/djq187"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20513808"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897878"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Isocitrate%20dehydrogenase%201%20and%202%20mutations%20in%20cancer%3A%20alterations%20at%20a%20crossroads%20of%20cellular%20metabolism&amp;author=ZJ.%20Reitman&amp;author=H.%20Yan&amp;journal=J%20Natl%20Cancer%20Inst&amp;volume=102&amp;issue=13&amp;pages=932-941&amp;publication_year=2010&amp;doi=10.1093%2Fjnci%2Fdjq187"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR54">Rohle D, Popovici-Muller J, Palaskas N et al (2013) An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 340(6132):626–630. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1126/science.1236062"><span class="RefSource">10.1126/science.1236062</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1126/science.1236062"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23558169"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985613"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=An%20inhibitor%20of%20mutant%20IDH1%20delays%20growth%20and%20promotes%20differentiation%20of%20glioma%20cells&amp;author=D.%20Rohle&amp;author=J.%20Popovici-Muller&amp;author=N.%20Palaskas&amp;journal=Science&amp;volume=340&amp;issue=6132&amp;pages=626-630&amp;publication_year=2013&amp;doi=10.1126%2Fscience.1236062"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR55">Saric T, Graef CI, Goldberg AL (2004) Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases. J Biol Chem 279(45):46723–46732. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1074/jbc.M406537200"><span class="RefSource">10.1074/jbc.M406537200</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1074/jbc.M406537200"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15328361"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Pathway%20for%20degradation%20of%20peptides%20generated%20by%20proteasomes%3A%20a%20key%20role%20for%20thimet%20oligopeptidase%20and%20other%20metallopeptidases&amp;author=T.%20Saric&amp;author=CI.%20Graef&amp;author=AL.%20Goldberg&amp;journal=J%20Biol%20Chem&amp;volume=279&amp;issue=45&amp;pages=46723-46732&amp;publication_year=2004&amp;doi=10.1074%2Fjbc.M406537200"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR56">Sasaki M, Knobbe CB, Munger JC et al (2012) IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488(7413):656–659. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature11323"><span class="RefSource">10.1038/nature11323</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature11323"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22763442"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005896"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=IDH1%28R132H%29%20mutation%20increases%20murine%20haematopoietic%20progenitors%20and%20alters%20epigenetics&amp;author=M.%20Sasaki&amp;author=CB.%20Knobbe&amp;author=JC.%20Munger&amp;journal=Nature&amp;volume=488&amp;issue=7413&amp;pages=656-659&amp;publication_year=2012&amp;doi=10.1038%2Fnature11323"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR57">Savaskan NE, Heckel A, Hahnen E et al (2008) Small interfering RNA—mediated neurodegeneration and alleviates. Nat Mad 14(6):629–632. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nm1772"><span class="RefSource">10.1038/nm1772</span></a></span>
                        <span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationContent" id="CR58">Snoek BC, de Wilt LH, Jansen G et al (2013) Role of E3 ubiquitin ligases in lung cancer. World J Clin Onco. 4(3):58–69. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.5306/wjco.v4.i3.58"><span class="RefSource">10.5306/wjco.v4.i3.58</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.5306/wjco.v4.i3.58"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Role%20of%20E3%20ubiquitin%20ligases%20in%20lung%20cancer&amp;author=BC.%20Snoek&amp;author=LH.%20Wilt&amp;author=G.%20Jansen&amp;journal=World%20J%20Clin%20Onco.&amp;volume=4&amp;issue=3&amp;pages=58-69&amp;publication_year=2013&amp;doi=10.5306%2Fwjco.v4.i3.58"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR59">Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1056/NEJMoa043330"><span class="RefSource">10.1056/NEJMoa043330</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1056/NEJMoa043330"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15758009"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Radiotherapy%20plus%20concomitant%20and%20adjuvant%20temozolomide%20for%20glioblastoma&amp;author=R.%20Stupp&amp;author=WP.%20Mason&amp;author=MJ.%20Bent&amp;journal=N%20Engl%20J%20Med&amp;volume=352&amp;issue=10&amp;pages=987-996&amp;publication_year=2005&amp;doi=10.1056%2FNEJMoa043330"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR60">Takano T, Lin JH, Arcuino G et al (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7(9):1010–1015. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nm0901-1010"><span class="RefSource">10.1038/nm0901-1010</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nm0901-1010"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11533703"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Glutamate%20release%20promotes%20growth%20of%20malignant%20gliomas&amp;author=T.%20Takano&amp;author=JH.%20Lin&amp;author=G.%20Arcuino&amp;journal=Nat%20Med&amp;volume=7&amp;issue=9&amp;pages=1010-1015&amp;publication_year=2001&amp;doi=10.1038%2Fnm0901-1010"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR61">Tanaka K, Sasayama T, Irino Y et al (2015) Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J Clin Invest 125(4):1–12. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1172/JCI78239DS1"><span class="RefSource">10.1172/JCI78239DS1</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1172/JCI78239"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Compensatory%20glutamine%20metabolism%20promotes%20glioblastoma%20resistance%20to%20mTOR%20inhibitor%20treatment&amp;author=K.%20Tanaka&amp;author=T.%20Sasayama&amp;author=Y.%20Irino&amp;journal=J%20Clin%20Invest&amp;volume=125&amp;issue=4&amp;pages=1-12&amp;publication_year=2015&amp;doi=10.1172%2FJCI78239DS1"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR62">Thunberg T (1920) Zur Kenntnis des intermediären Stoffwechsels und der dabei wirksamen Enzyme. Skand Arch Physiol 40(2):1–91<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1111/j.1748-1716.1920.tb01412.x"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Zur%20Kenntnis%20des%20intermedi%C3%A4ren%20Stoffwechsels%20und%20der%20dabei%20wirksamen%20Enzyme&amp;author=T.%20Thunberg&amp;journal=Skand%20Arch%20Physiol&amp;volume=40&amp;issue=2&amp;pages=1-91&amp;publication_year=1920"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR63">Tönjes M, Barbus S, Park YJ et al (2013) BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med 19(7):901–908. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nm.3217"><span class="RefSource">10.1038/nm.3217</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nm.3217"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23793099"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916649"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=BCAT1%20promotes%20cell%20proliferation%20through%20amino%20acid%20catabolism%20in%20gliomas%20carrying%20wild-type%20IDH1&amp;author=M.%20T%C3%B6njes&amp;author=S.%20Barbus&amp;author=YJ.%20Park&amp;journal=Nat%20Med&amp;volume=19&amp;issue=7&amp;pages=901-908&amp;publication_year=2013&amp;doi=10.1038%2Fnm.3217"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR64">Tsouko E, Khan AS, White MA et al (2014) Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis 3(5):e103. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/oncsis.2014.18"><span class="RefSource">10.1038/oncsis.2014.18</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/oncsis.2014.18"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24861463"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035695"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Regulation%20of%20the%20pentose%20phosphate%20pathway%20by%20an%20androgen%20receptor-mTOR-mediated%20mechanism%20and%20its%20role%20in%20prostate%20cancer%20cell%20growth&amp;author=E.%20Tsouko&amp;author=AS.%20Khan&amp;author=MA.%20White&amp;journal=Oncogenesis&amp;volume=3&amp;issue=5&amp;pages=e103&amp;publication_year=2014&amp;doi=10.1038%2Foncsis.2014.18"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR65">Turcan S, Rohle D, Goenka A et al (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483(7390):479–483. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature10866"><span class="RefSource">10.1038/nature10866</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/nature10866"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22343889"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351699"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=IDH1%20mutation%20is%20sufficient%20to%20establish%20the%20glioma%20hypermethylator%20phenotype&amp;author=S.%20Turcan&amp;author=D.%20Rohle&amp;author=A.%20Goenka&amp;journal=Nature&amp;volume=483&amp;issue=7390&amp;pages=479-483&amp;publication_year=2012&amp;doi=10.1038%2Fnature10866"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR66">van Lith SM, Navis AC, Verrijp K et al (2014) Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers? Biochim Biophys Acta - Rev Cancer 1846(1):66–74. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbcan.2014.04.004"><span class="RefSource">10.1016/j.bbcan.2014.04.004</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbcan.2014.04.004"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Glutamate%20as%20chemotactic%20fuel%20for%20diffuse%20glioma%20cells%3A%20are%20they%20glutamate%20suckers%3F&amp;author=SM.%20Lith&amp;author=AC.%20Navis&amp;author=K.%20Verrijp&amp;journal=Biochim%20Biophys%20Acta%20-%20Rev%20Cancer&amp;volume=1846&amp;issue=1&amp;pages=66-74&amp;publication_year=2014&amp;doi=10.1016%2Fj.bbcan.2014.04.004"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR67">Warburg O (1925) Über den Stoffwechsel der Carcinom-Zelle. Klin Wochenschr. 4(12):534–536. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1007/BF01058673"><span class="RefSource">10.1007/BF01058673</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1007/BF01726151"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=%C3%9Cber%20den%20Stoffwechsel%20der%20Carcinom-Zelle&amp;author=O.%20Warburg&amp;journal=Klin%20Wochenschr.&amp;volume=4&amp;issue=12&amp;pages=534-536&amp;publication_year=1925&amp;doi=10.1007%2FBF01058673"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR68">Warburg O (1954) Krebsforschung. Naturwissenschaften 41(21):485–486. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1038/1981145e0"><span class="RefSource">10.1038/1981145e0</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1007/BF00631820"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Krebsforschung&amp;author=O.%20Warburg&amp;journal=Naturwissenschaften&amp;volume=41&amp;issue=21&amp;pages=485-486&amp;publication_year=1954&amp;doi=10.1038%2F1981145e0"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR69">Warburg O, Wind F, Negelein E (1926) Über den Stoffwechsel von Tumoren im Körper. Klin Wochenschr 5(19):829–832. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1007/BF01726240"><span class="RefSource">10.1007/BF01726240</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1007/BF01726240"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=%C3%9Cber%20den%20Stoffwechsel%20von%20Tumoren%20im%20K%C3%B6rper&amp;author=O.%20Warburg&amp;author=F.%20Wind&amp;author=E.%20Negelein&amp;journal=Klin%20Wochenschr&amp;volume=5&amp;issue=19&amp;pages=829-832&amp;publication_year=1926&amp;doi=10.1007%2FBF01726240"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR70">Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21(3):297–308. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2012.02.014"><span class="RefSource">10.1016/j.ccr.2012.02.014</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2012.02.014"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22439925"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311998"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Metabolic%20reprogramming%3A%20a%20cancer%20hallmark%20even%20warburg%20did%20not%20anticipate&amp;author=PS.%20Ward&amp;author=CB.%20Thompson&amp;journal=Cancer%20Cell&amp;volume=21&amp;issue=3&amp;pages=297-308&amp;publication_year=2012&amp;doi=10.1016%2Fj.ccr.2012.02.014"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR71">Ward PS, Patel J, Wise DR et al (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3):225–234. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.01.020"><span class="RefSource">10.1016/j.ccr.2010.01.020</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.01.020"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20171147"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849316"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=The%20common%20feature%20of%20leukemia-associated%20IDH1%20and%20IDH2%20mutations%20is%20a%20neomorphic%20enzyme%20activity%20converting%20%CE%B1-ketoglutarate%20to%202-hydroxyglutarate&amp;author=PS.%20Ward&amp;author=J.%20Patel&amp;author=DR.%20Wise&amp;journal=Cancer%20Cell&amp;volume=17&amp;issue=3&amp;pages=225-234&amp;publication_year=2010&amp;doi=10.1016%2Fj.ccr.2010.01.020"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR72">Weil-Malherbe H (1936) The metabolism of glutamic acid in brain. Stud brain Metab 95(1):665–676<span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=The%20metabolism%20of%20glutamic%20acid%20in%20brain&amp;author=H.%20Weil-Malherbe&amp;journal=Stud%20brain%20Metab&amp;volume=95&amp;issue=1&amp;pages=665-676&amp;publication_year=1936"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR73">Wise DR, Ward PS, Shay JES et al (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci USA 108(49):19611–19616. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1073/pnas.1117773108"><span class="RefSource">10.1073/pnas.1117773108</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1073/pnas.1117773108"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22106302"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241793"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Hypoxia%20promotes%20isocitrate%20dehydrogenase-dependent%20carboxylation%20of%20%CE%B1-ketoglutarate%20to%20citrate%20to%20support%20cell%20growth%20and%20viability&amp;author=DR.%20Wise&amp;author=PS.%20Ward&amp;author=JES.%20Shay&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=108&amp;issue=49&amp;pages=19611-19616&amp;publication_year=2011&amp;doi=10.1073%2Fpnas.1117773108"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR74">Wong AJ, Ruppert JM, Bigner SH et al (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89(7):2965–2969<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1073/pnas.89.7.2965"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1557402"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC48784"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Structural%20alterations%20of%20the%20epidermal%20growth%20factor%20receptor%20gene%20in%20human%20gliomas&amp;author=AJ.%20Wong&amp;author=JM.%20Ruppert&amp;author=SH.%20Bigner&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=89&amp;issue=7&amp;pages=2965-2969&amp;publication_year=1992"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR75">Xia L, Wu B, Fu Z et al (2015) Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies. Oncotarget 6(19):17354–17365<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.18632/oncotarget.4008"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26220714"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627313"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Prognostic%20role%20of%20IDH%20mutations%20in%20gliomas%3A%20a%20meta-analysis%20of%2055%20observational%20studies&amp;author=L.%20Xia&amp;author=B.%20Wu&amp;author=Z.%20Fu&amp;journal=Oncotarget&amp;volume=6&amp;issue=19&amp;pages=17354-17365&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR76">Xu W, Yang H, Liu Y et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1):17–30. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.12.014"><span class="RefSource">10.1016/j.ccr.2010.12.014</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.ccr.2010.12.014"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21251613"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229304"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Oncometabolite%202-hydroxyglutarate%20is%20a%20competitive%20inhibitor%20of%20%CE%B1-ketoglutarate-dependent%20dioxygenases&amp;author=W.%20Xu&amp;author=H.%20Yang&amp;author=Y.%20Liu&amp;journal=Cancer%20Cell&amp;volume=19&amp;issue=1&amp;pages=17-30&amp;publication_year=2011&amp;doi=10.1016%2Fj.ccr.2010.12.014"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR77">Yan H, Parsons DW, Jin G et al (2009) Mutations in Gliomas. N Engl J Med 360(8):765–773. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1056/NEJMoa0808710"><span class="RefSource">10.1056/NEJMoa0808710</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1056/NEJMoa0808710"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19228619"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820383"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Mutations%20in%20Gliomas&amp;author=H.%20Yan&amp;author=DW.%20Parsons&amp;author=G.%20Jin&amp;journal=N%20Engl%20J%20Med&amp;volume=360&amp;issue=8&amp;pages=765-773&amp;publication_year=2009&amp;doi=10.1056%2FNEJMoa0808710"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR78">Yao P-S, Kang D-Z, Lin R-Y et al (2014) Glutamate/glutamine metabolism coupling between astrocytes and glioma cells: neuroprotection and inhibition of glioma growth. Biochem Biophys Res Commun 450(1):295–299. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbrc.2014.05.120"><span class="RefSource">10.1016/j.bbrc.2014.05.120</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.bbrc.2014.05.120"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24944014"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Glutamate%2Fglutamine%20metabolism%20coupling%20between%20astrocytes%20and%20glioma%20cells%3A%20neuroprotection%20and%20inhibition%20of%20glioma%20growth&amp;author=P-S.%20Yao&amp;author=D-Z.%20Kang&amp;author=R-Y.%20Lin&amp;journal=Biochem%20Biophys%20Res%20Commun&amp;volume=450&amp;issue=1&amp;pages=295-299&amp;publication_year=2014&amp;doi=10.1016%2Fj.bbrc.2014.05.120"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR79">Ye Z, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1:4383–4391<span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Glioma%20cells%20release%20excitotoxic%20concentrations%20of%20glutamate%20glioma%20cells%20release%20excitotoxic%20concentrations%20of%20glutamate&amp;author=Z.%20Ye&amp;author=H.%20Sontheimer&amp;journal=Cancer%20Res&amp;volume=1&amp;pages=4383-4391&amp;publication_year=1999"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR80">Zhang J, Fan J, Venneti S et al (2014) Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Mol Cell 56(2):205–218. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.molcel.2014.08.018"><span class="RefSource">10.1016/j.molcel.2014.08.018</span></a></span>
                        <span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1016/j.molcel.2014.08.018"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25242145"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" target="_blank" rel="noopener noreferrer" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224619"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener noreferrer" class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Asparagine%20plays%20a%20critical%20role%20in%20regulating%20cellular%20adaptation%20to%20glutamine%20depletion&amp;author=J.%20Zhang&amp;author=J.%20Fan&amp;author=S.%20Venneti&amp;journal=Mol%20Cell&amp;volume=56&amp;issue=2&amp;pages=205-218&amp;publication_year=2014&amp;doi=10.1016%2Fj.molcel.2014.08.018"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationContent" id="CR81">Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, Ding J, Lei Q, Guan KL, Xiong Y (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324(5924):261–265. doi:<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1126/science.1170944"><span class="RefSource">10.1126/science.1170944</span></a></span>
                        <span class="Occurrences"></span></div></li></ol></div></section><section class="Section1 RenderAsSection1"><h2 class="Heading" id="copyrightInformation">Copyright information</h2><div class="ArticleCopyright content"><div class="ArticleCopyright">© The Author(s) 2016</div><div id="License" class="License"><p class="SimplePara"><strong class="EmphasisTypeBold ">Open Access</strong>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<span class="ExternalRef"><a target="_blank" rel="noopener noreferrer" href="http://creativecommons.org/licenses/by/4.0/"><span class="RefSource">http://creativecommons.org/licenses/by/4.0/</span></a></span>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</p></div></div></section><section id="authorsandaffiliations" class="Section1 RenderAsSection1"><h2 class="Heading">Authors and Affiliations</h2><div class="content authors-affiliations u-interface"><ul class="test-contributor-names"><li itemscope="" itemtype="http://schema.org/Person" class="u-mb-2 u-pt-4 u-pb-4"><span itemprop="name" class="authors-affiliations__name">Andreas Maus</span><ul class="authors-affiliations__indexes u-inline-list" data-role="AuthorsIndexes"><li data-affiliation="affiliation-1">1</li><li data-affiliation="affiliation-2">2</li></ul></li><li itemscope="" itemtype="http://schema.org/Person" class="u-mb-2 u-pt-4 u-pb-4"><span itemprop="name" class="authors-affiliations__name">Godefridus J. Peters</span><ul class="authors-affiliations__indexes u-inline-list" data-role="AuthorsIndexes"><li data-affiliation="affiliation-1">1</li></ul><span class="author-information"><span class="author-information__contact u-icon-before icon--email-before"><a href="mailto:gj.peters@vumc.nl" title="gj.peters@vumc.nl" itemprop="email" class="gtm-email-author">Email author</a></span></span></li></ul><ol class="test-affiliations"><li class="affiliation" data-test="affiliation-1" data-affiliation-highlight="affiliation-1" itemscope="" itemtype="http://schema.org/Organization"><span class="affiliation__count">1.</span><span class="affiliation__item"><span itemprop="department" class="affiliation__department">Department of Medical Oncology</span><span itemprop="name" class="affiliation__name">VU University Medical Center</span><span itemprop="city" class="affiliation__city">Amsterdam</span><span itemprop="country" class="affiliation__country">The Netherlands</span></span></li><li class="affiliation" data-test="affiliation-2" data-affiliation-highlight="affiliation-2" itemscope="" itemtype="http://schema.org/Organization"><span class="affiliation__count">2.</span><span class="affiliation__item"><span itemprop="name" class="affiliation__name">University of Gottingen</span><span itemprop="city" class="affiliation__city">Gottingen</span><span itemprop="country" class="affiliation__country">Germany</span></span></li></ol></div></section></div>
                                <aside class="content-type-about" id="AboutThisContent">
    <h2 class="Heading" id="aboutcontent">About this article</h2>
    <div class="content bibliographic-information">
                <div id="crossMark" class="crossmark">
            <a data-crossmark="10.1007%2Fs00726-016-2342-9" class="gtm-crossmark" target="_blank" rel="noopener noreferrer" href="https://crossmark.crossref.org/dialog/?doi=10.1007%2Fs00726-016-2342-9" title="Verify currency and authenticity via CrossMark">
                <span class="u-screenreader-only">CrossMark</span>
                <svg class="CrossMark" id="crossmark-icon" width="57" height="81">
                    <image width="57" height="81" alt="Verify currency and authenticity via CrossMark" src="/springerlink-static/25538376/images/png/crossmark.png" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/springerlink-static/25538376/images/svg/crossmark.svg"></image>
                </svg>
            </a>
        </div>

            <div class="crossmark__adjacent">
                <div class="u-mb-16">
	<dl class="article-cite">
		<dt class="test-cite-heading">
			Cite this article as:
		</dt>
		<dd id="citethis-text">Maus, A. & Peters, G.J. Amino Acids (2017) 49: 21. https://doi.org/10.1007/s00726-016-2342-9</dd>
	</dl>
</div>

                    <ul class="bibliographic-information__list bibliographic-information__list--inline">
        <li class="bibliographic-information__item">
            <span class="bibliographic-information__title"><abbr title="Digital Object Identifier">DOI</abbr></span>
            <span class="bibliographic-information__value u-overflow-wrap" id="doi-url">https://doi.org/10.1007/s00726-016-2342-9</span>
        </li>
            <li class="bibliographic-information__item">
                <span class="bibliographic-information__title">Publisher Name</span>
                <span class="bibliographic-information__value" id="publisher-name">Springer Vienna</span>
            </li>
            <li class="bibliographic-information__item">
                <span class="bibliographic-information__title">Print ISSN</span>
                <span class="bibliographic-information__value" id="print-issn">0939-4451</span>
            </li>
            <li class="bibliographic-information__item ">
                <span class="bibliographic-information__title">Online ISSN</span>
                <span class="bibliographic-information__value" id="electronic-issn">1438-2199</span>
            </li>

        
    </ul>

                <ul class="bibliographic-information__list">
    <li class="bibliographic-information__item">
        <a id="about-journal" class="bibliographic-information__misc-links gtm-about-this" title="Visit Springer.com for information about this article&#39;s journal"
           href="//www.springer.com/journal/726/about">About this journal</a>
    </li>
    <li class="bibliographic-information__item">
        <a id="reprintsandpermissions-link" class="u-external" target="_blank" rel="noopener noreferrer" href="https://s100.copyright.com/AppDispatchServlet?publisherName&#x3D;Springer&amp;orderBeanReset&#x3D;true&amp;orderSource&#x3D;SpringerLink&amp;author&#x3D;Andreas+Maus&amp;licenseType&#x3D;CC+BY&amp;issueNum&#x3D;1&amp;contentID&#x3D;10.1007%2Fs00726-016-2342-9&amp;openAccess&#x3D;true&amp;endPage&#x3D;32&amp;publicationDate&#x3D;2016&amp;startPage&#x3D;21&amp;volumeNum&#x3D;49&amp;title&#x3D;Glutamate+and+%CE%B1-ketoglutarate%3A+key+players+in+glioma+metabolism&amp;imprint&#x3D;The+Author%28s%29&amp;publication&#x3D;0939-4451&amp;authorAddress&#x3D;PO+Box+7057%2C+1007+MB%2C+Amsterdam%2C+The+Netherlands" title="Visit RightsLink for information about reusing this article">Reprints and Permissions</a>
    </li>
</ul>
            </div>
        
    </div>
</aside>

                                <div class="collapsible-section uptodate-recommendations gtm-recommendations">
    <h2 class="uptodate-recommendations__title collapsible-section__heading gtm-recommendations__title" id="uptodaterecommendations">Personalised recommendations</h2>
    <div class="collapsible-section__content">
        <div class="uptodate-recommendations__container">
             <link rel="uptodate-inline" href="/springerlink-static/25538376/css/recommendations.css"/>
        </div>
    </div>
</div>
                                            <div class="sticky-banner 
            u-interface u-js-screenreader-only" aria-hidden="true" data-component="SpringerLink.StickyBanner" data-namespace="hasButton">
                <div class="sticky-banner__container">
                        <div class="citations" data-component="SV.Dropdown" data-namespace="citationsSticky">
        <h3 class="u-h4" data-role="button-dropdown__title">
    <span>Cite</span>
    <span class="hide-text-small">article</span>
</h3>
<ul class="citations__content" data-role="button-dropdown__content">
        <li>
            <a href="//citation-needed.springer.com/v2/references/10.1007/s00726-016-2342-9?format&#x3D;refman&amp;flavour&#x3D;citation"
               title="Download this article&#39;s citation as a .RIS file" class="gtm-export-citation" data-gtmlabel="RIS">
                <span class="citations__extension" data-gtmlabel="RIS">
                    <svg class="u-vertical-align-absolute" width="12" height="14" viewBox="0 0 12 14" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#0176C3"/></svg>
                    .RIS
                </span>
                <span class="citations__types">
                        <span>
                            Papers
                        </span>
                        <span>
                            Reference Manager
                        </span>
                        <span>
                            RefWorks
                        </span>
                        <span>
                            Zotero
                        </span>
                </span>
            </a>
        </li>
        <li>
            <a href="//citation-needed.springer.com/v2/references/10.1007/s00726-016-2342-9?format&#x3D;endnote&amp;flavour&#x3D;citation"
               title="Download this article&#39;s citation as a .ENW file" class="gtm-export-citation" data-gtmlabel="ENW">
                <span class="citations__extension" data-gtmlabel="ENW">
                    <svg class="u-vertical-align-absolute" width="12" height="14" viewBox="0 0 12 14" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#0176C3"/></svg>
                    .ENW
                </span>
                <span class="citations__types">
                        <span>
                            EndNote
                        </span>
                </span>
            </a>
        </li>
        <li>
            <a href="//citation-needed.springer.com/v2/references/10.1007/s00726-016-2342-9?format&#x3D;bibtex&amp;flavour&#x3D;citation"
               title="Download this article&#39;s citation as a .BIB file" class="gtm-export-citation" data-gtmlabel="BIB">
                <span class="citations__extension" data-gtmlabel="BIB">
                    <svg class="u-vertical-align-absolute" width="12" height="14" viewBox="0 0 12 14" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#0176C3"/></svg>
                    .BIB
                </span>
                <span class="citations__types">
                        <span>
                            BibTeX
                        </span>
                        <span>
                            JabRef
                        </span>
                        <span>
                            Mendeley
                        </span>
                </span>
            </a>
        </li>
</ul>
    </div>

                        <div class="share-this" data-component="SV.Dropdown" data-namespace="shareThisSticky">
        <h3 class="u-h4" data-role="button-dropdown__title">
    <span>Share</span>
    <span class="hide-text-small">article</span>
</h3>
<ul class="share-this__content" data-role="button-dropdown__content">
    <li>
        <a class="test-shareby-email-link gtm-shareby-email-link" href="mailto:?to&#x3D;&amp;subject&#x3D;Read%20this%20article%20on%20SpringerLink&amp;body&#x3D;Glutamate%20and%20%CE%B1-ketoglutarate%3A%20key%20players%20in%20glioma%20metabolism%0A%0Ahttps%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9" title="Share this article via email">
            <span class="share-this__types">
                <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><g transform="translate(3 5)"><rect fill="#F9F9F9" width="18" height="14" rx="2"/><path d="M1 2.006v9.988c0 .557.446 1.006.995 1.006h14.01c.549 0 .995-.449.995-1.006v-9.988c0-.557-.446-1.006-.995-1.006h-14.01c-.549 0-.995.449-.995 1.006zm-1 0c0-1.108.893-2.006 1.995-2.006h14.01c1.102 0 1.995.897 1.995 2.006v9.988c0 1.108-.893 2.006-1.995 2.006h-14.01c-1.102 0-1.995-.897-1.995-2.006v-9.988zM9 9l7-4v-1.443l-7 4-7-4v1.443z" fill="#666"/></g></g></svg>
                <span>Email</span>
            </span>
        </a>
    </li>
    <li>
        <a class="test-shareby-facebook-link gtm-shareby-facebook-link" href="https://www.facebook.com/sharer/sharer.php?u&#x3D;https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9" target="_blank" rel="noopener noreferrer" title="Share this article via Facebook">
            <span class="share-this__types">
                <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><path d="M12.717 19.091h-2.66v-6.274h-1.329v-2.162h1.329v-1.298c0-1.763.75-2.813 2.883-2.813h1.775v2.162h-1.11c-.83 0-.885.302-.885.866l-.004 1.082h2.011l-.235 2.162h-1.775v6.274z" fill="#666"/></g></svg>
                <span>Facebook</span>
            </span>
        </a>
    </li>
    <li>
        <a class="test-shareby-twitter-link gtm-shareby-twitter-link" href="https://twitter.com/intent/tweet?text&#x3D;I%27m%20reading%20this%20on%20%23springerlink&amp;url&#x3D;https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9" target="_blank" rel="noopener noreferrer" title="Share this article via Twitter">
            <span class="share-this__types">
                <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><path d="M16.651 9.189c.485-.306.858-.792 1.033-1.371-.454.284-.957.49-1.493.601-.428-.482-1.039-.783-1.715-.783-1.298 0-2.349 1.11-2.349 2.478 0 .194.019.384.06.564-1.952-.104-3.684-1.089-4.843-2.59-.202.367-.318.793-.318 1.247 0 .859.415 1.618 1.045 2.063-.385-.013-.748-.126-1.065-.31v.03c0 1.201.809 2.203 1.886 2.43-.198.058-.405.087-.62.087-.151 0-.299-.015-.442-.044.299.984 1.166 1.702 2.195 1.721-.805.665-1.818 1.061-2.919 1.061-.19 0-.377-.011-.561-.034 1.04.703 2.275 1.113 3.602 1.113 4.323 0 6.686-3.777 6.686-7.052l-.006-.321c.459-.35.859-.786 1.173-1.283-.422.197-.875.33-1.349.39z" fill="#666"/></g></svg>
                <span>Twitter</span>
            </span>
        </a>
    </li>
        <li>
            <a class="test-shareby-linkedin-link gtm-shareby-linkedin-link" href="https://www.linkedin.com/shareArticle?mini&#x3D;true&amp;url&#x3D;https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9&amp;title&#x3D;Glutamate and α-ketoglutarate: key players in glioma metabolism&amp;summary&#x3D;Glioblastoma multiforme (GBM), or grade IV astrocytoma, is the most common type of primary brain tumor. It has a devastating prognosis with a 2-year-overall survival rate of only 26 % after standard treatment, which includes surgery, radiation, and …" target="_blank" rel="noopener noreferrer" title="Share this article via LinkedIn">
                <span class="share-this__types">
                    <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><path d="M6.821 10.044h2.126v7.41h-2.126v-7.41zm1.009-.927h-.015c-.77 0-1.269-.566-1.269-1.284 0-.732.514-1.287 1.299-1.287.784 0 1.267.554 1.282 1.285 0 .717-.498 1.286-1.297 1.286zm9.625 8.338h-2.411v-3.835c0-1.004-.377-1.688-1.206-1.688-.634 0-.987.462-1.151.908-.062.159-.052.382-.052.606v4.01h-2.389s.031-6.794 0-7.411h2.389v1.163c.141-.509.904-1.234 2.122-1.234 1.511 0 2.698 1.067 2.698 3.361v4.121z" fill="#666"/></g></svg>
                    <span>LinkedIn</span>
                </span>
            </a>
        </li>
        <li>
            <a class="gtm-shareby-sharelink-link" data-test="shareable-link" href="/sharelink/10.1007/s00726-016-2342-9" target="_blank" rel="noopener noreferrer" title="Get shareable link">
                <span class="share-this__types">
                    <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24"><path fill="#666" d="M9 7c-2.8 0-5 2.2-5 5s2.2 5 5 5h2v-2h-2c-1.7 0-3-1.3-3-3s1.3-3 3-3h2v-2h-2zm6 0c2.8 0 5 2.2 5 5s-2.2 5-5 5h-2v-2h2c1.7 0 3-1.3 3-3s-1.3-3-3-3h-2v-2h2zm-1 4c.5 0 1 .4 1 1s-.5 1-1 1h-4c-.5 0-1-.4-1-1s.5-1 1-1h4z"/></svg>
                    <span>Shareable link</span>
                </span>
            </a>
        </li>
</ul>
    </div>

                                    <a href="/content/pdf/10.1007%2Fs00726-016-2342-9.pdf" target="_blank" class="c-button c-button--blue c-button__icon-right gtm-pdf-link" title="Download this article in PDF format" rel="noopener noreferrer">
            <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" version="1.1"><g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g fill="#fff"><g transform="translate(12.000000, 5.000000)"><path d="M7 7.3L7 1C7 0.4 6.6 0 6 0 5.4 0 5 0.4 5 1L5 7.3 3.5 5.7C3.1 5.3 2.5 5.3 2.1 5.7L2.1 5.7C1.7 6.1 1.7 6.7 2.1 7.1L5.3 10.3C5.7 10.7 6.3 10.7 6.7 10.3L9.9 7.1C10.3 6.7 10.3 6.1 9.9 5.7L9.9 5.7C9.5 5.3 8.9 5.3 8.5 5.7L7 7.3 7 7.3ZM0 13C0 12.4 0.5 12 1 12L11 12C11.6 12 12 12.4 12 13 12 13.6 11.5 14 11 14L1 14C0.4 14 0 13.6 0 13L0 13Z"/></g></g></g></svg>
            <span class="hide-text-small">Download</span>
            <span>PDF</span>
        </a>

                </div>
            </div>




                            </div>
                        </div>

                        <aside class="main-sidebar-right u-interface">
                            <div data-role="sticky-wrapper">
                                <div class="main-sidebar-right__content u-composite-layer" data-component="SpringerLink.StickySidebar">
                                    <div class="article-actions" id="article-actions">
                                        <h2 class="u-screenreader-only">Actions</h2>


                                        <div class="u-js-hide u-js-show-two-col">
                                            

                                                    <div class="download-article test-pdf-link">
                                                                <a href="/content/pdf/10.1007%2Fs00726-016-2342-9.pdf" target="_blank" class="c-button c-button--blue c-button__icon-right gtm-pdf-link" title="Download this article in PDF format" rel="noopener noreferrer">
            <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" version="1.1"><g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g fill="#fff"><g transform="translate(12.000000, 5.000000)"><path d="M7 7.3L7 1C7 0.4 6.6 0 6 0 5.4 0 5 0.4 5 1L5 7.3 3.5 5.7C3.1 5.3 2.5 5.3 2.1 5.7L2.1 5.7C1.7 6.1 1.7 6.7 2.1 7.1L5.3 10.3C5.7 10.7 6.3 10.7 6.7 10.3L9.9 7.1C10.3 6.7 10.3 6.1 9.9 5.7L9.9 5.7C9.5 5.3 8.9 5.3 8.5 5.7L7 7.3 7 7.3ZM0 13C0 12.4 0.5 12 1 12L11 12C11.6 12 12 12.4 12 13 12 13.6 11.5 14 11 14L1 14C0.4 14 0 13.6 0 13L0 13Z"/></g></g></g></svg>
            <span class="hide-text-small">Download</span>
            <span>PDF</span>
        </a>

                                                    </div>


                                                <div class="citations" data-component="SV.Dropdown" data-namespace="citations">
        <h3 class="u-h4" data-role="button-dropdown__title">
    <span>Cite</span>
    <span class="hide-text-small">article</span>
</h3>
<ul class="citations__content" data-role="button-dropdown__content">
        <li>
            <a href="//citation-needed.springer.com/v2/references/10.1007/s00726-016-2342-9?format&#x3D;refman&amp;flavour&#x3D;citation"
               title="Download this article&#39;s citation as a .RIS file" class="gtm-export-citation" data-gtmlabel="RIS">
                <span class="citations__extension" data-gtmlabel="RIS">
                    <svg class="u-vertical-align-absolute" width="12" height="14" viewBox="0 0 12 14" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#0176C3"/></svg>
                    .RIS
                </span>
                <span class="citations__types">
                        <span>
                            Papers
                        </span>
                        <span>
                            Reference Manager
                        </span>
                        <span>
                            RefWorks
                        </span>
                        <span>
                            Zotero
                        </span>
                </span>
            </a>
        </li>
        <li>
            <a href="//citation-needed.springer.com/v2/references/10.1007/s00726-016-2342-9?format&#x3D;endnote&amp;flavour&#x3D;citation"
               title="Download this article&#39;s citation as a .ENW file" class="gtm-export-citation" data-gtmlabel="ENW">
                <span class="citations__extension" data-gtmlabel="ENW">
                    <svg class="u-vertical-align-absolute" width="12" height="14" viewBox="0 0 12 14" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#0176C3"/></svg>
                    .ENW
                </span>
                <span class="citations__types">
                        <span>
                            EndNote
                        </span>
                </span>
            </a>
        </li>
        <li>
            <a href="//citation-needed.springer.com/v2/references/10.1007/s00726-016-2342-9?format&#x3D;bibtex&amp;flavour&#x3D;citation"
               title="Download this article&#39;s citation as a .BIB file" class="gtm-export-citation" data-gtmlabel="BIB">
                <span class="citations__extension" data-gtmlabel="BIB">
                    <svg class="u-vertical-align-absolute" width="12" height="14" viewBox="0 0 12 14" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#0176C3"/></svg>
                    .BIB
                </span>
                <span class="citations__types">
                        <span>
                            BibTeX
                        </span>
                        <span>
                            JabRef
                        </span>
                        <span>
                            Mendeley
                        </span>
                </span>
            </a>
        </li>
</ul>
    </div>

                                                <div class="share-this" data-component="SV.Dropdown" data-namespace="shareThis">
        <h3 class="u-h4" data-role="button-dropdown__title">
    <span>Share</span>
    <span class="hide-text-small">article</span>
</h3>
<ul class="share-this__content" data-role="button-dropdown__content">
    <li>
        <a class="test-shareby-email-link gtm-shareby-email-link" href="mailto:?to&#x3D;&amp;subject&#x3D;Read%20this%20article%20on%20SpringerLink&amp;body&#x3D;Glutamate%20and%20%CE%B1-ketoglutarate%3A%20key%20players%20in%20glioma%20metabolism%0A%0Ahttps%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9" title="Share this article via email">
            <span class="share-this__types">
                <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><g transform="translate(3 5)"><rect fill="#F9F9F9" width="18" height="14" rx="2"/><path d="M1 2.006v9.988c0 .557.446 1.006.995 1.006h14.01c.549 0 .995-.449.995-1.006v-9.988c0-.557-.446-1.006-.995-1.006h-14.01c-.549 0-.995.449-.995 1.006zm-1 0c0-1.108.893-2.006 1.995-2.006h14.01c1.102 0 1.995.897 1.995 2.006v9.988c0 1.108-.893 2.006-1.995 2.006h-14.01c-1.102 0-1.995-.897-1.995-2.006v-9.988zM9 9l7-4v-1.443l-7 4-7-4v1.443z" fill="#666"/></g></g></svg>
                <span>Email</span>
            </span>
        </a>
    </li>
    <li>
        <a class="test-shareby-facebook-link gtm-shareby-facebook-link" href="https://www.facebook.com/sharer/sharer.php?u&#x3D;https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9" target="_blank" rel="noopener noreferrer" title="Share this article via Facebook">
            <span class="share-this__types">
                <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><path d="M12.717 19.091h-2.66v-6.274h-1.329v-2.162h1.329v-1.298c0-1.763.75-2.813 2.883-2.813h1.775v2.162h-1.11c-.83 0-.885.302-.885.866l-.004 1.082h2.011l-.235 2.162h-1.775v6.274z" fill="#666"/></g></svg>
                <span>Facebook</span>
            </span>
        </a>
    </li>
    <li>
        <a class="test-shareby-twitter-link gtm-shareby-twitter-link" href="https://twitter.com/intent/tweet?text&#x3D;I%27m%20reading%20this%20on%20%23springerlink&amp;url&#x3D;https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9" target="_blank" rel="noopener noreferrer" title="Share this article via Twitter">
            <span class="share-this__types">
                <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><path d="M16.651 9.189c.485-.306.858-.792 1.033-1.371-.454.284-.957.49-1.493.601-.428-.482-1.039-.783-1.715-.783-1.298 0-2.349 1.11-2.349 2.478 0 .194.019.384.06.564-1.952-.104-3.684-1.089-4.843-2.59-.202.367-.318.793-.318 1.247 0 .859.415 1.618 1.045 2.063-.385-.013-.748-.126-1.065-.31v.03c0 1.201.809 2.203 1.886 2.43-.198.058-.405.087-.62.087-.151 0-.299-.015-.442-.044.299.984 1.166 1.702 2.195 1.721-.805.665-1.818 1.061-2.919 1.061-.19 0-.377-.011-.561-.034 1.04.703 2.275 1.113 3.602 1.113 4.323 0 6.686-3.777 6.686-7.052l-.006-.321c.459-.35.859-.786 1.173-1.283-.422.197-.875.33-1.349.39z" fill="#666"/></g></svg>
                <span>Twitter</span>
            </span>
        </a>
    </li>
        <li>
            <a class="test-shareby-linkedin-link gtm-shareby-linkedin-link" href="https://www.linkedin.com/shareArticle?mini&#x3D;true&amp;url&#x3D;https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00726-016-2342-9&amp;title&#x3D;Glutamate and α-ketoglutarate: key players in glioma metabolism&amp;summary&#x3D;Glioblastoma multiforme (GBM), or grade IV astrocytoma, is the most common type of primary brain tumor. It has a devastating prognosis with a 2-year-overall survival rate of only 26 % after standard treatment, which includes surgery, radiation, and …" target="_blank" rel="noopener noreferrer" title="Share this article via LinkedIn">
                <span class="share-this__types">
                    <svg width="24" height="24" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g fill="none"><path fill-opacity="0" fill="#fff" d="M0 0h24v24h-24z"/><path d="M6.821 10.044h2.126v7.41h-2.126v-7.41zm1.009-.927h-.015c-.77 0-1.269-.566-1.269-1.284 0-.732.514-1.287 1.299-1.287.784 0 1.267.554 1.282 1.285 0 .717-.498 1.286-1.297 1.286zm9.625 8.338h-2.411v-3.835c0-1.004-.377-1.688-1.206-1.688-.634 0-.987.462-1.151.908-.062.159-.052.382-.052.606v4.01h-2.389s.031-6.794 0-7.411h2.389v1.163c.141-.509.904-1.234 2.122-1.234 1.511 0 2.698 1.067 2.698 3.361v4.121z" fill="#666"/></g></svg>
                    <span>LinkedIn</span>
                </span>
            </a>
        </li>
        <li>
            <a class="gtm-shareby-sharelink-link" data-test="shareable-link" href="/sharelink/10.1007/s00726-016-2342-9" target="_blank" rel="noopener noreferrer" title="Get shareable link">
                <span class="share-this__types">
                    <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24"><path fill="#666" d="M9 7c-2.8 0-5 2.2-5 5s2.2 5 5 5h2v-2h-2c-1.7 0-3-1.3-3-3s1.3-3 3-3h2v-2h-2zm6 0c2.8 0 5 2.2 5 5s-2.2 5-5 5h-2v-2h2c1.7 0 3-1.3 3-3s-1.3-3-3-3h-2v-2h2zm-1 4c.5 0 1 .4 1 1s-.5 1-1 1h-4c-.5 0-1-.4-1-1s.5-1 1-1h4z"/></svg>
                    <span>Shareable link</span>
                </span>
            </a>
        </li>
</ul>
    </div>

                                        </div>
                                    </div>
                                    <nav class="toc" aria-label="article contents">
    <h2 class="u-h4 u-screenreader-only">Table of contents</h2>
    <ul id="article-contents" class="article-contents" role="menu">
            <li role="menuitem">
                <a title="Article" href="#enumeration"><span class="u-overflow-ellipsis">Article</span></a>
            </li>
            <li role="menuitem">
                <a title="Abstract" href="#Abs1"><span class="u-overflow-ellipsis">Abstract</span></a>
            </li>
            <li role="menuitem">
                <a title="Introduction" href="#Sec1"><span class="u-overflow-ellipsis">Introduction</span></a>
            </li>
            <li role="menuitem">
                <a title="Glutamate and α-ketoglutarate in glioma metabolism" href="#Sec2"><span class="u-overflow-ellipsis">Glutamate and α-ketoglutarate in glioma metabolism</span></a>
            </li>
            <li role="menuitem">
                <a title="Metabolic compensations to anti-tumor therapy" href="#Sec11"><span class="u-overflow-ellipsis">Metabolic compensations to anti-tumor therapy</span></a>
            </li>
            <li role="menuitem">
                <a title="Differences between IDH-wt and IDH-mutant gliomas" href="#Sec15"><span class="u-overflow-ellipsis">Differences between IDH-wt and IDH-mutant gliomas</span></a>
            </li>
            <li role="menuitem">
                <a title="2HG directly interferes with ATP synthase" href="#Sec21"><span class="u-overflow-ellipsis">2HG directly interferes with ATP synthase</span></a>
            </li>
            <li role="menuitem">
                <a title="Conclusion" href="#Sec22"><span class="u-overflow-ellipsis">Conclusion</span></a>
            </li>
            <li role="menuitem">
                <a title="Notes" href="#Notes"><span class="u-overflow-ellipsis">Notes</span></a>
            </li>
            <li role="menuitem">
                <a title="References" href="#Bib1"><span class="u-overflow-ellipsis">References</span></a>
            </li>
            <li role="menuitem">
                <a title="Copyright information" href="#copyrightInformation"><span class="u-overflow-ellipsis">Copyright information</span></a>
            </li>
            <li role="menuitem">
                <a title="Authors and Affiliations" href="#authorsandaffiliations"><span class="u-overflow-ellipsis">Authors and Affiliations</span></a>
            </li>
            <li role="menuitem">
                <a title="About this article" href="#aboutcontent"><span class="u-overflow-ellipsis">About this article</span></a>
            </li>
    </ul>
</nav>

                                </div>
                                        <div class="skyscraper-ad u-hide" data-component="SpringerLink.GoogleAds" data-namespace="skyscraper"></div>

                            </div>
                        </aside>
                    </div>
                </article>
            </main>

            <section class="banner banner--cookies-policy u-js-hide" data-component="SpringerLink.CookiePolicy">
    <div class="banner__content u-interface">
        <h2 class="u-screenreader-only">Cookies</h2>
        <span class="banner__cookie-text">We use cookies to improve your experience with our site.</span>
        <a class="banner__link banner__link--cookie" href="/termsandconditions#cookies">More information</a>

        <form class="banner__form" action="/acceptcookies" method="POST">
            <button class="u-link-like banner__right-ui">Accept</button>
        </form>
    </div>
</section>

                <footer class="footer u-interface">
        <div class="footer__aside-wrapper">
            <div class="footer__content">
                <div class="footer__aside">
                    <p class="footer__strapline">Over 10 million scientific documents at your fingertips</p>
                                <div class="footer__edition" data-component="SpringerLink.EditionSwitcher">
                                    <h3 class="u-hide" data-role="button-dropdown__title" data-btn-text="Switch between Academic &#38; Corporate Edition">Switch Edition</h3>
                                    <ul data-role="button-dropdown__content">
                                        <li class="selected"><a href="/siteEdition/link" id="siteedition-academic-link">Academic Edition</a></li>
                                        <li><a href="/siteEdition/rd" id="siteedition-corporate-link">Corporate Edition</a></li>
                                    </ul>
                                </div>
                </div>
            </div>
        </div>
        <div class="footer__content">
            <ul class="footer__nav">
                <li>
                    <a href="/">Home</a>
                </li>
                <li>
                    <a href="/impressum">Impressum</a>
                </li>
                <li>
                    <a href="/termsandconditions">Legal Information</a>
                </li>
                <li>
                    <a href="/accessibility" class="gtm-footer-accessibility">Accessibility</a>
                </li>
                <li>
                    <a id="contactus-footer-link" href="/contactus">Contact Us</a>
                </li>
            </ul>
            <a class="parent-logo"
               target="_blank" rel="noreferrer noopener"
               href="//www.springernature.com"
               title="Go to Springer Nature">
                <span class="u-screenreader-only">Springer Nature</span>
                <svg width="125" height="12">
                    <image width="125" height="12" alt="Springer Nature logo"
                           src="/springerlink-static/25538376/images/png/springernature.png"
                           xmlns:xlink="http://www.w3.org/1999/xlink"
                           xlink:href="/springerlink-static/25538376/images/svg/springernature.svg">
                    </image>
                </svg>
            </a>

            <p class="footer__copyright">&copy; 2017 Springer International Publishing AG. Part of <a target="_blank" rel="noreferrer noopener" href="//www.springernature.com">Springer Nature</a>.</p>

                <p class="footer__user-access-info">
                    <span>Not logged in</span>
                    <span>Not affiliated</span>
                    <span>139.5.240.251</span>
                </p>
        </div>
    </footer>

        </div>
        
<script type="text/javascript">
    (function() {
        var linkEl = document.querySelector('.js-ctm');
        if (window.matchMedia && window.matchMedia(linkEl.media)) {
            (function(h){h.className = h.className.replace('no-js', 'js')})(document.documentElement);
            window.SpringerLink = window.SpringerLink || {};
            window.SpringerLink.staticLocation = '/springerlink-static/25538376';
            var scriptJquery = document.createElement('script');
            var scriptMain = document.createElement('script');
            scriptJquery.async = false;
            scriptJquery.src = window.SpringerLink.staticLocation + '/js/jquery-3.2.1.min.js';
            scriptMain.async = false;
            scriptMain.src =  window.SpringerLink.staticLocation + '/js/main.js';
            document.body.appendChild(scriptJquery);
            document.body.appendChild(scriptMain);
        }
    })();
</script>

<script type="text/javascript">
    window.onload = function() {
    var linkEl = document.querySelector('.js-ctm');


    function viewport() {
        if (document.documentElement.clientWidth < 620) {
            size = 'small';
        }
        else if(document.documentElement.clientWidth < 1075 ) {
            size = 'medium';
        }
        else {
            size = 'wide';
        }
        return size;
    }

    function reportForMouseEvent(linkCssSelector, nolardUrl, experiment, abgroup) {
        var counter = 0;
        $('body').delegate(linkCssSelector, 'click', function() {
            if(counter == 0) {
                reportConversion(nolardUrl, experiment, abgroup);
                counter++;
            }
        });
    }

    function reportParticipation(nolardUrl, experiment, abgroup) {
        $.ajax({ url: nolardUrl + '/participate/' + experiment + '/' + abgroup });
    }

    function reportConversion(nolardUrl, experiment, abgroup) {
        $.ajax({ url: nolardUrl + '/convert/' + experiment + '/' + abgroup });
    }
    };
</script>

<script class="kxct" data-id="KDqyaFZ_" data-timing="async" data-version="3.0" type="text/javascript">
 window.Krux||((Krux=function(){Krux.q.push(arguments)}).q=[]);
 (function(){
   var k=document.createElement('script');k.type='text/javascript';k.async=true;
   k.src=(location.protocol==='https:'?'https:':'http:')+'//cdn.krxd.net/controltag/KDqyaFZ_.js';
   var s=document.getElementsByTagName('script')[0];s.parentNode.insertBefore(k,s);
 }());
</script>

<script>
    window.Krux||((Krux=function(){Krux.q.push(arguments);}).q=[]);
    (function(){
        function retrieve(n){
            var m, k='kx'+n;
            if (window.localStorage) {
                return window.localStorage[k] || "";
            } else if (navigator.cookieEnabled) {
                m = document.cookie.match(k+'=([^;]*)');
                return (m && unescape(m[1])) || "";
            } else {
                return '';
            }
        }
        Krux.user = retrieve('user');
        Krux.segments = retrieve('segs') && retrieve('segs').split(',') || [];
    })();
</script>

    <script type="text/javascript">
        var googletag = googletag || {};
        googletag.cmd = googletag.cmd || [];
        (function() {
            var gads = document.createElement('script');
            gads.async = true;
            gads.type = 'text/javascript';
            var useSSL = 'https:' == document.location.protocol;
            gads.src = (useSSL ? 'https:' : 'http:') +
                    '//www.googletagservices.com/tag/js/gpt.js';
            var node = document.getElementsByTagName('script')[0];
            node.parentNode.insertBefore(gads, node);
        })();
    </script>
    <script type="text/javascript" id="googletag-push">
        
            var adSlot = '270604982/springerlink/726/article';
        

        var definedSlots = [
                {slot: [728, 90], containerName: 'doubleclick-leaderboard-ad'},
                {slot: [160, 600], containerName: 'doubleclick-ad'},
        ];

        googletag.cmd.push(function() {
                googletag.pubads().setTargeting("doi","10.1007-s00726-016-2342-9");
                googletag.pubads().setTargeting("kwrd",["Glioma","Glutamate","Alpha-ketoglutarate","Isocitrate_dehydrogenase","Branched_chain_amino_acids"]);
                googletag.pubads().setTargeting("pmc",["L","L14005","C11006","C12029","L00004","L1403X","L25066"]);
                googletag.pubads().setTargeting("BPID",["1"]);
                googletag.pubads().setTargeting("edition","academic");
                googletag.pubads().setTargeting("sucode","Biomedical and Life Sciences");
                googletag.pubads().setTargeting("eissn","1438-2199");
                googletag.pubads().setTargeting("pissn","0939-4451");
                googletag.pubads().setTargeting("ksg",Krux.segments);
                googletag.pubads().setTargeting("kuid",Krux.uid);
                googletag.pubads().setTargeting("logged","N");
            googletag.pubads().enableSingleRequest();
            googletag.pubads().enableAsyncRendering();
            googletag.enableServices();
        });
    </script>

        
        <span id="chat-widget" class="u-hide"></span>
                    <noscript>
                <img aria-hidden="true" role="presentation" src="https://ssl-springer.met.vgwort.de/na/vgzm.415900-10.1007-s00726-016-2342-9" width='1' height='1' alt='' />
            </noscript>

    </body>
</html>
